Anti-Inflammatory Properties of Oklahoma Grapes by Peterson, Sandra Kay
 




   By 
   SANDRA K. PETERSON 
   Bachelor of Science in Microbiology  
   Oklahoma State University 
   Stillwater, OK 
   1994 
 
 
   Submitted to the Faculty of the 
   Graduate College of the 
   Oklahoma State University 
   in partial fulfillment of 
   the requirements for 
   the Degree of 
   MASTER OF SCIENCE 
   May 2010  
   ANTI-INFLAMMATORY PROPERTIES OF 
OKLAHOMA GRAPES 





   Thesis Approved: 
 
 
   Dr. Edralin A. Lucas 
   Thesis Adviser 
 
   Dr. Brenda J. Smith 
 
   Dr. Eric Stafne    
 
  Dr. A. Gordon Emslie 










I would like to extend the deepest appreciation to my advisor, Dr. Edralin Lucas, 
for all of her support and patience over the past three years. Dr. Lucas has made a 
substantial impact on my life as a mentor and a friend. Without her guidance and 
persistent help this dissertation would not have been possible. 
I would also like to thank my committee members, Dr. Brenda Smith and Dr. 
Eric Stafne, for their time and support. 
Words alone cannot express the thanks I owe to my family and friends for their 
constant encouragement and assistance, especially my friend, Stephany Parker, who 





































TABLE OF CONTENTS 
 
Chapter          Page 
 
I. INTRODUCTION ......................................................................................................8 
 
 Specific Aims .........................................................................................................12 
 Limitations .............................................................................................................12 
  
 
II. REVIEW OF LITERATURE..................................................................................14 
  
 Inflammation and Chronic Disease ........................................................................14 
 Pro-Inflammatory Molecules .................................................................................17 
 Interleukin-6 (IL-6) ..........................................................................................18 
 Tumor Necrosis Factor-α (TNF-α) ..................................................................21 
 Nitric Oxide (NO) ............................................................................................22 
 Pharmacological Options for Inflammation ...........................................................24 
 Bioactive Components in Grapes ...........................................................................25 
 Anti-Inflammatory Properties of Grapes ...............................................................30 
 In vitro Studies .................................................................................................30 
 Oxidative Stress .........................................................................................30 
Inflammatory Markers ...............................................................................31 
Other Effects ..............................................................................................34 
Animal Studies .................................................................................................35 
 Platelet Aggregation ...................................................................................35 
Lipid Profile and Oxidative Stress .............................................................37 
Inflammatory Markers ...............................................................................40 
Other Effects ..............................................................................................41 
Human Studies .................................................................................................42 
 Platelet Aggregation ...................................................................................42 
 Oxidative Stress .........................................................................................43 
 Inflammatory Markers ...............................................................................44 





III. METHODOLOGY ................................................................................................50 
 
 Specific Aim 1 .......................................................................................................50 
      Grape Juice Preparation ....................................................................................50 
      Total Phenolic, Anthocyanin, and Flavonoid Content ......................................52 
      Ferric Reducing Ability (FRA) Assay ..............................................................53 
      Cell Propagation and Treatment .......................................................................53 
           Cell Viability .....................................................................................................54 
      Assessment of Nitric Oxide ..............................................................................55 
 Specific Aim 2 .......................................................................................................55 
            Grape Extract Preparation and Analyses .........................................................55 
            Cell Treatment .................................................................................................56 
 Specific Aim 3 .......................................................................................................58 
       Cell Treatment .................................................................................................58 
       RNA Extraction ...............................................................................................58 
       Assessment of Inflammatory Gene Expression by Real Time-PCR ...............59 
ELISA Assays for TNF-α and IL-6 .................................................................60 
 Statistical Analysis .................................................................................................61 
              
 
IV. FINDINGS .............................................................................................................62 
 
 Specific Aim 1 .......................................................................................................62 
 Total Phenolic, Flavonoid, Anthocyanin, and Anti-Oxidant Capacity  
 of Grape Juice ..................................................................................................62 
       Effect of Grape Juice on Nitric Oxide Production and Cell Viability  
            of LPS-stimulated RAW264.7 Macrophages ..................................................69 
 Specific Aim 2 .......................................................................................................74 
       Total Phenolic, Flavonoid, and Anthocyanin Concentration 
            of Grape Extract ...............................................................................................74 
       Effect of Grape Extract on Nitric Oxide Production and Cell Viability 
            of LPS-stimulated RAW264.7Macrophages ...................................................76 
 Specific Aim 3 .......................................................................................................79 
       Nitric Oxide, TNF-α, and IL-6 .........................................................................79 
       Real Time PCR ................................................................................................81 
 







LIST OF TABLES 
 
 
Table           Page 
 
1: Nutritional Analysis for Raw, American Type Grapes ........................................... 26 
2: Polyphenol Composition of Grapes and Grape Products ....................................... 29 
3: Harvest Time of Grapes Grown at Cimarron Valley Research Station, Perkins,             
Oklahoma Fall 2007 ................................................................................................ 52 
4: Ten Grapes Varieties Chosen for in vitro Investigation of Anti-Inflammatory 
Properties of Grape Extract ..................................................................................... 56 
5: Primer Sequences used for Real-time PCR ............................................................ 60 
6: Total Phenolic, Flavonoid, Anthocyanin, and Anti-Oxidant Capacity of 
Oklahoma Grapes by Pureed Preparation ............................................................... 65 
7: Total Phenolic, Flavonoid, Anthocyanin, and Anti-Oxidant Capacityof 
Oklahoma Grapes by Smashed Preparation ............................................................ 66 
 8: Correlation of Nitric Oxide (NO) Production from LPS-stimulated Macrophage 
with Total Phenolic, Flavonoid, and Anthocyanin Content from the Juice of 
Oklahoma Grapes .................................................................................................... 71 
 9: Total Phenolic, Flavonoid, and Anthocyanin Concentration of Extract from Ten 








LIST OF FIGURES 
 
 
Figure           Page 
 
 
1:  Effect of Grape Juice Preparation on (A) Total Phenolic, (B) Flavonoid, (C) 
Anthocyanin, and (D) Anti-oxidant Capacity (FRAP) from Combined Data of 
Thirty-three Oklahoma Grape Varieties ................................................................. 63 
2:  Correlation of (A) Total Phenolic, (B) Flavonoid, and (C) Anthocyanin                    
Concentrations with Anti-Oxidant Capacity (FRAP) of Grape Juice ..................... 68 
3:  Effect of Juice from Thirty-three Oklahoma Grape Varieties on Nitric Oxide 
Production in LPS-stimulated RAW264.7 Macrophage ......................................... 70 
4:  Effects of Juice from Different Oklahoma Grape Varieties on Cell Viability of 
LPS-stimulated RAW264.7 Macrophage ............................................................... 71 
5:  Effect of Different Concentration of Grape Juice from Thirty-three Oklahoma 
Grape Varieties on (A) Nitric Oxide Production and (B) Cell Viability of LPS-
stimulated RAW264.7 Macrophage........................................................................ 73 
6:   Effects of Extract from Ten Oklahoma Grape Varieties on (A) Nitric Oxide 
Production and (B) Cell Viability in LPS-stimulated RAW264.7 Macrophage ..... 77 
7:  Effect of Different Concentrations of Grape Extract from Ten Oklahoma Grape 
Varieties on (A) Nitric Oxide Production and (B) Cell Viability of LPS-
Stimulated RAW264.7 Macrophage ....................................................................... 78 
8:   Effect of Different Concentration of Grape Extract from Ten Oklahoma Grape 
Varieties on Nitric Oxide Production of LPS-stimulated RAW264.7 
Macrophage ............................................................................................................. 79 
9:  Effect of Resveratrol and Rubaiyat Grape Extract on (A) Nitric Oxide, (B) TNF-
α and (C) IL-6 Production of LPS-stimulated RAW264.7 Macrophages ............... 81 
10: Effect of Resveratrol and Rubaiyat Grape Extract on Relative Abundance of 
mRNA for (A) IL-6, (B) iNOS, (C) COX-2, (D) TNF-α in RAW264.7 















          Many debilitating chronic conditions such as cardiovascular disease (CVD) [1], 
obesity [2], diabetes [3] and cancer [4] have been linked to chronic inflammation. CVD 
continues to be the number one cause of death for Americans [5]. In 2009, an estimated 
81.1 million Americans were diagnosed with one or more forms of CVD and  9,000 
people died each day from some form of the disease [6].  Obesity and diabetes are also 
prevalent conditions in our society.  Statistics for 2007 have shown that 32% of American 
adults over the age of 20 are obese and an estimated 7.8% of the population have diabetes 
[7].  The prevalence of cancer is also alarming with an estimated half million Americans 
will die from this terrifying disease in 2009 [8]. Because of the relationship of 
inflammation with these chronic conditions, reducing or preventing inflammation may be 
one way to combat these diseases. 
Currently, pharmacological agents used to reduce inflammation include 
corticosteroids, specifically glucocorticoids, and nonsteroidal anti-inflammatory drugs 
(NSAIDs).  Glucocorticoids increase the transcription for anti-inflammatory cytokines 
such as  interleukin (IL)-10 and IL-1, and inhibit the expression of pro-inflammatory 
cytokines, inducible nitric oxide synthase, IL-2 receptors, and adhesion molecules [9].  
An example of a glucocorticoid is prednisone which is used to treat conditions such as 
chronic obstructive pulmonary disease [10], rheumatoid arthritis [11], Crohn’s disease 
[12],  and prostate cancer [13]. NSAIDs, on the other hand, block the cyclooxygenase 
(COX) enzymes and reduce prostaglandin synthesis resulting in the reduction of 
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inflammation, pain, and fever [14]. Two commonly used NSAID’s are Celebrex and 
aspirin. Unfortunately, these pharmacological anti-inflammatory agents are associated 
with several side effects. Aspirin is cardioprotective by decreasing platelet aggregation,  
but causes gastrointestinal distress [15]. Celebrex, on the other hand, may increase the 
risk of cardiovascular thrombotic events, myocardial infarction, and stroke [16].  
Many people prefer a natural option as opposed to a pharmacological approach in 
preventing chronic conditions. Fortunately, a number of natural products are also 
associated with reduction of inflammation. For example, omega-3 fatty acids including 
eicosapentanoic acid (EPA) and docosahexanoic acid (DHA), decrease the production of 
pro-inflammatory molecules such as eicosanoids, cytokines, and reactive oxygen species 
(ROS) [17]. They can also reduce the expression of adhesion molecules by inhibiting 
arachidonic acid metabolism and altering the activation of the nuclear factor –κB (NF-
κB) [17].  Another natural approach to reduce  inflammation by inhibiting COX-2 
production is the use of common spices turmeric and ginger due to its active ingredient 
curcumin [18].  Proteolytic enzymes found in the intestine of the silkworm called 
serrapeptase [17], bromelain found in  pineapples [19] and hypericin a chemical from 
St.John’s Wort [20] are other remedies found to reduce inflammation.  
Another remedy for reducing inflammation may be the utilization of active 
compounds found in fruits and vegetables. For example, vitamin C inhibits tumor 
necrosis factor (TNF)-α from activating NF-κB thereby preventing the production of the 
pro-inflammatory cytokines IL-2 [21]. Vitamin E, a vitamin found in vegetable oils, also 
reduces the production of pro-inflammatory cytokines such as IL-1β, IL-6, and TNF-α 
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[22]. Phytochemicals such as genistein, quercetin, and resveratrol are chemicals produced 
in grapes which have also been shown to reduce inflammation [23].  
As in plants, phytochemicals induce various physiological responses and perform 
specific function in the human body. Genistein protects plants against fungal disease [24] 
and in humans functions as an anti-inflammatory agent by inhibiting prostaglandin E2 
and COX-2 activity [25]. Quercetin guards plants against stress by acting as an anti-
oxidant and removing toxic peroxides from plant cells [26]. In the human body, quercetin 
acts similarly by reducing ROS and decrease the expression of vascular cell adhesion 
molecules [27]. Resveratrol, like genistein, protects plants against fungal infections [28] 
and in the human is effective in protecting against inflammation by the inhibition of NF-
κB, COX-2, and numerous other  pro-inflammatory molecules [29]. Increased scientific 
understanding of the benefit of fruits and vegetables and their impact on health has led to 
an interest in polyphenols and their importance to the human body. 
Polyphenols are phytochemicals of plant origin that possess one or more phenol 
rings used as building blocks to create thousands of molecules that protect plants against 
disease, animals, insects, and also have a role in reproduction and pigmentation [30].  
Consumption of foods rich in polyphenols have been found to have numerous health 
properties including the capabilities to reduce inflammation and prevent oxidation [31].  
Because of these properties, polyphenols are being widely investigated for their role in 
reducing many chronic conditions [32].   
When considering the role of nutrition in reducing the incidence of chronic 
disease, the ‘French Paradox’ has long been a phenomenon of interest [33].  The French 
consume a high fat diet; yet, their incidence of atherosclerosis is far below that of 
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Americans.  Among the potential dietary contributions, it is believed that consumption of 
wine with their meal has helped prevent or reduce CVD among the French.  Initially, 
researchers thought alcohol contributed to the cardioprotective effect of the inhibition of 
platelet aggregation.  Research has now shown that the polyphenols of the grapes from 
which the wine was made contributes to benefit the heart [33].    
Grapes contain hundreds of different phenolic compounds but the most common 
and highest concentrations include gallic acid, quercetin, caffeic acid, catechin, 
epicatechin, rutin, myristicin, resveratrol, anthocyanins, proanthocyanidins, flavonoids, 
and flavan-3-ols [34]. Phenolic content is greatly influenced by the variety of grape and  
the environmental conditions during the growing season such as temperature and the 
amount of precipitation [35]. Soil conditions, climate, water hardness, and disease are 
other factors contributing to the concentration of polyphenols [36].  Research has found 
that the harvest time of the grapes throughout the year [37] and the differences of the 
grapes within the same variety [38] can create different polyphenolic profiles for grapes 
of the same variety.  
The increasing trend in Oklahoma towards grape production has sparked the need 
to understand the health benefits associated with grapes grown locally, including their 
anti-inflammatory properties. Increased knowledge of the health benefits of grapes may 
further help grape growers to promote their products and increase their consumption 
which will help Oklahoma’s viticulture and agritourism business. The hypothesis to be 
tested is that the varieties of Oklahoma grapes with high concentrations of total phenolic 









1.  To determine the phenolic content, anti-oxidant capacity, and anti-inflammatory 
properties of juice from different varieties of grapes grown in Oklahoma. 
2. To assess the in vitro anti-inflammatory properties of extract from Oklahoma 
grape varieties with high and low total phenolics content (five varieties each) 
using LPS-stimulated macrophage. 
3. To compare the effect of the grape extract from an Oklahoma grape variety to that 




  The study utilizes grapes grown only in Cimarron Valley Research Station 
(Perkins, OK) which is not necessarily representative of the state as far as the condition 
of the soil, precipitation and other environmental conditions or disease.  These conditions 
are known to influence the composition and concentration of the phenolic compounds in 
grapes. 
  There is no way to be certain that the extraction process used removed 100% of 
the polyphenols found in the grapes, although, the results were reasonable when 
compared to data of similar varieties. Nonetheless, the same procedure was used for all 
varieties and sufficient for comparative purposes. Uniformity of the final product cannot 
be verified. Temperature control, vacuum pressure, spillage, and other experimental 
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variables are all factors that we attempted to control for uniformity of the extract. The 
stability of polyphenols during processing and storage cannot be controlled and is 
currently unknown.  
 This study used the total extract and not the individual phenolic compound rather 
than whole grapes in an attempt to determine the effects of the grape polyphenols rather 
than other components of the grape such as carbohydrates. This study is an in vitro study 
using murine macrophages and because of this should be interpreted with caution. 
Studies with animals and subsequently humans are necessary to confirm the findings of 





REVIEW OF LITERATURE 
 
Inflammation and Chronic Disease 
 
 Inflammation is a normal process for protection against foreign antigens such as 
bacteria, virus, and parasites or for the repair of an injury [39]. The majority of foreign 
antigens are kept out of the body by physical barriers like the skin and mucosal 
membranes of the innate immune response.  If the antigen gets past the physical barriers, 
macrophages and neutrophils migrate to the site of the antigen, engulf and phagocytize or 
destroy the antigen [40]. The antigen is then displayed on the cell surface creating an 
antigen-presenting cell. T-helper cells that can recognize the same antigen interact with 
the antigen-presenting macrophage to stimulate the secretion of interleukin (IL-2) which 
causes the proliferation of cytotoxic T cells and B cells.  The functional properties of B 
cells and T cells enables adaptive immunity to be extremely powerful.  In both, innate 
and adaptive immune function, numerous pro-inflammatory and anti-inflammatory 
molecules are produced to create a self-regulatory effect, thereby ending the immune 
response when the antigen is removed [40].  In some people, diseases or genetic disorders 
interfere with the self-regulation of the immune response and cause a condition called 
autoimmune disease.  
 Chronic inflammation has been implicated in the development of  many chronic 
diseases such as cardiovascular disease (CVD) [1], obesity [2], diabetes [3], and cancer 
[4]. CVD alone affects 81.1 million people in the United States [6, 41] and this number 
continues to grow as the prevalence of obesity and diabeties continues to increase. 
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According to the Behavioral Risk Factor Surveillance System, only 15.9%  individuals 
were reported as obese in 1995 in comparison to 26.6% of adults in 2008 [42]. As obesity 
increases, so do other chronic diseases associated with inflammation, such as diabetes, 
which is projected to affect 23.6 million people in the US in 2009. Eighteen million of 
these people will be diagnosed and receive treatment for diabetes while the other 5.7 
million people will remain undiagnosed [43]. Cancer is also a disease associated with 
chronic inflammation from which an estimated one half  million Americans died from in 
2009 [8].   
Chronic inflammation plays a major role in the onset of atherosclerosis or the 
development of fatty deposits in blood vessels as one of the primary causes of CVD [44].  
Monocytes are called to the site by monocyte chemotactic protein 1 (MCP-1) released by 
damaged endothelial cells lining the blood vessels. The monocytes infiltrate the space 
below the endothelium (the intima), differentiate into macrophages, and release more 
cytokines and other pro-inflammatory molecules. Low density lipoproteins (LDL) also 
enter the intima where they undergo oxidation (oxLDL) and promote endothelial and 
smooth muscle cell activation, secretion of inflammatory mediators, and expression of 
adhesion molecules, a sequence of steps that culminates in leukocyte accumulation in the 
intima. Oxidized LDL is taken up into the macrophages via scavenger receptors resulting 
in the formation of foam cells, a prominent feature of atherosclerotic plaques [45-47]. 
Chronic inflammation is also associated with obesity [48] and is a factor in the 
onset and progression of diabetes 2 [3]. Obesity is associated with an increased risk of 
developing insulin resistance, type 2 diabetes, atherosclerosis, and other chronic diseases. 
Traditionally, adipose tissue was considered to passively store triacylglycerols and 
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release free fatty acids. Now, it is recognized to be an active endocrine organ able to 
secrete a large number of pro-inflammatory molecules. The white adipose tissue (WAT) 
represents the majority of adipose tissue in humans and is the primary site of energy 
storage.  The WAT is made up primarily of adipose cells and the tissue matrix which 
contains preadipocytes, endothelial cells, fibroblasts, leukocytes, and macrophages. 
Adipose tissue contains numerous activated adipocytes, macrophages, and T-
lymphocytes that produce increased amounts of  adipokines, and pro-inflammatory 
cytokines [49].  Some pro-inflammatory molecules produced in the WAT [50] include 
adiponectin, IL-1β, IL-6, tumor necrosis factor (TNF-α), monocyte chemoattractant 
protein (MCP-1) and monocyte inflammatory protein (MIP). The combination of obesity 
with other risk factors such as hypercholesterolemia and hypertension is likely to 
heighten the systemic inflammation to enhance the progression and severity of CVD [49].   
Adipocytes produce a variety of chemokines that modulate the movement of 
inflammatory cells into the adipose tissue, such as monocytes that are then transformed 
into macrophages. The macrophage are induced to produce the proinflammatory 
cytokines TNF-α and IL-6. The increase of adipocytes creates insulin resistance. The 
high level of circulating insulin increases the free fatty acid (FFA) release from 
adipocytes and enhances delivery to the liver. The liver increases hepatic production of 
very low-density lipoprotein and the enzymatic activity of lipoprotein lipase is decreased. 
This decreases the production of high density lipoproteins.  Other types of FFAs activate 
toll-like receptor 4 (TLR4) to produce IL-6.  Adipocytes are responsible for controlling 
the hormones adiponectin and leptin. Adiponectin enhances insulin sensitivity in muscle 
and liver and increases FFA oxidation in several tissues, including muscle fibers.  It also 
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decreases serum FFA, glucose, and triacylglycerol concentration. Plasma adiponetin 
concentrations fall with increased obesity.  Adiponectin concentrations are inversely 
correlated with insulin resistance and hyperinsulinemia, which lead to type 2 diabetes and 
metabolic syndrome. Plasma leptin concentrations are highly correlated with body mass 
index (BMI). However, in most obese individuals, leptin concentrations are already high 
because of the increased amount of leptin-secreting adipose tissue.  It appears that with 
increased leptin concentration, the hormone induces target cells to become resistant to its 
actions. Some of the actions to reduce circulating FFA and triacylglycerol are due to 
increased fat oxidation.  The increase in fat oxidation is mediated by activating the 
enzyme adenosine monophosphate (AMP)-activated protein kinase which increases 
glucose transport in muscle. AMP-activated protein kinase is also activated by exercise 
which also increases fat oxidation and reduces insulin resistane.  Thus, the adipocyte 
hormones and exercise act via a similar signal transduction pathway to increase fat 
oxidation and promote insulin sensitivity [51]. 
Cancer associated inflammation is characterized by the induction of cell cycling 
for tissue growth and repair. The initiation, promotion and expansion of tumors may be 
influenced by numerous components that function in the inflammatory response [52].   
 
Pro-Inflammatory Molecules 
 Cytokines and nitric oxide (NO) are pro-inflammatory molecules released from 
activated immune cells including  macrophages and lymphocytes.  These molecules have 
different signalling functions during inflammation to ochestrate an effective immune 
response against the antigen thereby protecting the body from disease. The cytokines IL-
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6 and TNF-α, as well as NO will be the focus of this review due to their extensive role in 
the initiation of the inflammatory response. 
 Cytokines are polypeptides secreted by various cells of the immune system.  They 
are involved in acute and chronic inflammation as mediators of the inflammatory 
response by autocrine and paracrine actions. The major classes of cytokines include 
interleukins (IL), tumor necrosis factor (TNF), colony stimulating factors (CSF),  
transforming growth factor (TGF) and interferons (IFN) [53].  Cytokines may function 
either as pro-inflammatory or anti-inflammatory agents. 
 
Interleukin-6 (IL-6) 
 The interleukins (IL) were first described as signals for communication between 
white blood cells [54]. Interleukins are the primary messengers and directors of the 
immune system and can cause cellular proliferation, cell activation, inflammation, 
physiologic changes such as fever and pain, allergies and growth [54].  There are 
currently thirty-five identified interleukins, however, only IL-6 is focused on in this 
project.  
IL-6 is a cytokine secreted by T-cells, macrophages, and other cells such as 
smooth muscle cells and osteoclast. IL-6 is involved in a wide variety of biological 
functions [54] including the stimulation of osteoblast formation. IL-6 was shown to be 
secreted from muscle and osteoclast during exercise [54]. Smooth muscle cells, T-cells 
and macrophage produce IL-6 primarily as a pro-inflammatory cytokine [55]  that 
stimulates the immune response by forming a receptor complex consisting of a specific 
IL-6 binding protein (IL-6R) and a signal-transducing subunit (gp130). The IL-6/IL-6R 
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complex induces several intracellular signalling events including the activation of 
transcription factor [54].  The transcription factor, in turn, promotes the transcription of 
pro- and anti- inflammatory proteins encoded  in the cellular DNA. Generally, in acute 
inflammation, IL-6 acts as an anti-inflammatory cytokine that inhibits TNF-α activity by 
preventing the activation of NF-κB thereby ending the acute inflammation response [56].  
In chronic inflammation, IL-6 is acts as a pro-inflammatory molecule which induces the 
production of C-reactive protein (CRP) from the liver.  The increase in circulating IL-6 
and CRP are important markers of chronic inflammation [56]. 
 Acute inflammation is characterized by the accumulation of neutrophils to the site 
of infection while chronic inflammation involves the accumulation of monocytes and 
their differentiation into macrophages [56].  IL-6 is important in this transition between 
acute and chronic inflammation.  During the early stages of infection, IL-6 and IL-6R 
form a complex which activates endothelial cells to induce expression of adhesion 
molecules such as IL-8 (a chemoattractant for neutrophils) and MCP-1. Neutrophils 
attracted by IL-8 bring more IL-6R attached to their membrane. Pro-inflammatory 
cytokines induce the neutrophil to release the IL-6R which is then free to bind with IL-6. 
This new IL-6/IL-6R complex will ligate with gp130 on the endothelial cell membrane 
and increase IL-6 and MCP-1 secretion, but not IL-8, thereby causing the transition from 
neutrophil to monocyte recruitment [56]. 
Circulating levels of IL-6 are directly correlated with adiposity and insulin 
resistance [57]. Approximately 15-35%  of IL-6 circulating in the blood originates from 
the adipose tissue [50].  While adipocytes are capable of producing IL-6, it is thought the 
other cells in the adipose tissue such as macrophages and endothelial cells are the major 
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contributors of IL-6 [58, 59].  The macrophages in the cell matrix are responsible for 
contributing approximately 50% of the WAT derived IL-6 [60].  
Several studies have been done on IL-6 in relation to chronic conditions [50, 54, 
56, 58, 59, 61-68].  IL-6 has been found to be three times higher in obese individuals 
compared to lean individuals [62].  It has also been found to be required in the 
development of collagen and antigen induced arthritis [69-72]. In colorectal cancer, the 
IL-6 concentration in cancerous colon tissue was found to be approximately eight times 
higher than normal colon tissue [63]. IL-6 is significantly correlated with the staging of 
colorectal cancer [73]. However, the relationship between macrophage-derived and 
tumor-derived IL-6 has remained unclear until a study by Li and colleagues (2009).  
Their results indicated that macrophages in tumor infiltrates could release IL-6 creating a 
condition in which colon cancer cells secrete IL-6 [64]. 
IL-6 production differs between type 1 and type 2 diabetes. IL-6 is secreted from 
monocytes when adiponectin activates the NFκB pathway. Whereas circulating 
adiponectin is reduced in the sera of patients with type 2 diabetes and in patients with 
CVD [74], systemic adiponectin is elevated in type 1diabetes mellitus. Therefore, patients 
with type 1 diabetes should produce higher levels of IL-6. A study by Abke and 
colleagues [75] compared the circulating IL-6 and adiponectin from patients with type 1 
diabetes to control patients to determine why they are more prone to cardiovascular 
disease. The type 1 diabetics had double the adiponectin of the controls, yet, when the IL-
6 was measured type 1 diabetics had only half the concentration of the controls. This 
study indicates that adiponectin signal transduction pathways are impaired in type 1 
diabetes monocytes decreasing the amount of IL-6 produced [75, 76]. 
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Tumor Necrosis Factor-α (TNF-α)    
TNF-α or cachectin is produced primarily by monocytes and macrophages [77]. 
Adipose tissue produces TNF-α in large quantities as with IL-6.  Although, adipocytes 
produce some IL-6, adipocytes do not produce any TNF-α.  TNF-α is produced by 
macrophages which are entrapped in the adipose matrix. TNF-α is involved in the 
initiation of three pathways of inflammation:  activation of NF-κB, activation of the 
mitogen-activated protein kinases (MAPK) pathway, and induction of cell death 
signaling [78].  
In the first pathway, TNF-α binds to transmembrane receptors  such as toll-like 
receptors, RANK, and TNF receptor (TNFR) activating the enzyme IκB kinase (IKK). 
Under normal conditions, IκB is bound to NF-κB in the cytosol. Phosphorylation of IκB 
caused it to be released from NF-κB. The IκB is then degraded by a proteosome and the 
liberated NF-κB is now free to move from the cytosol into the nucleus where it acts as a 
“rapid-acting” primary transcription factor and upregulates genes involved in cytokine 
production and  T-cell development, maturation, and proliferation [78].  
NF-κB activation is terminated when the newly synthesized IκB moves into the 
nucleus to bind the NF-κB and relocates it back into the cytoplasm via a nuclear export 
signal, thus, making NF-κB self-limiting [79]. NF-κB induces gene expression of a large 
number of immune molecules including cytokines (IL-2, IL-6, IL-8, IFN-γ, TNF-α), 
growth factors (granulocyte, monocyte, and granulocyte-monocyte colony-stimulating 
factors), immune receptors (T-cell receptor, MHC class I, IL-2 receptors), adhesion 
molecules (E-selectin, ICAM-1, VCAM-1), and inducible nitric oxide synthase (iNOS) 
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[80]. Furthermore, NF-κB plays an important role in both apoptosis and cellular 
proliferation [77].  
The second pathway activated by TNF-α is the MAPK cascade. MAPK are 
serine/threonine specific protein kinases that respond to extracellular mitogens and 
regulate gene expression, mitosis, differentiation, and cell apoptosis [81].  MAPK 
positively regulates expression of many genes involved in inflammation, such as those 
coding for TNF-α, IL-1β, IL-6, IL-8, cyclooxygenase-2, and collagenase-1&3 [81].  A 
large number of cellular processes are mediated by the interacting network of MAPK 
from extracellular signals to their intracellular targets [82]. The MAPK cascades 
influence a variety of nuclear, membrane, cytosolic and cytoskeletal targets [82].  
The induction of death signaling is a minor role of TNF-α in inflammation. Two 
TNF receptors possess death domains; TNF receptor 1 (TNFR1) and Fas receptor. These 
receptors are both transmembrane proteins which can activate the caspase cascade 
responsible for programmed death or apoptosis [83].  
 
Nitric Oxide (NO)  
NO is an inorganic molecule synthesized from the amino acid L-arginine by the 
enzyme, nitric oxide synthetase (NOS). There are at two types of this enzyme: 
constitutive and inducible.  The constitutive enzymes (endothelial NOS (eNOS) and 
neuronal NOS (nNOS)) are cytosolic, calcium/calmodulin dependent, and release NO for 
short periods in response to receptor or physical stimulation. NO released by these 
enzymes are responsible for numerous physiological responses. NO has regulatory effects 
(vascular tone and permeability and cell adhesion), protective effects (anti-oxidant and 
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inhibits leukocyte adhesion), and deleterious effects (inhibits enzyme function, promotes 
DNA damage and induces lipid peroxidation) [84].  Inducible NOS (iNOS) is induced by 
the activation of macrophages, endothelial cells, and numerous other cells [85].  This 
enzyme differs from eNOS and nNOS in that it is calcium independent and releases NO 
for extended periods of time [86]. NO plays an active role in signaling as well as being a 
cytotoxic or regulatory effector molecule of the innate immune response. Because NO 
has an unpaired electron, it is highly reactive and readily binds to superoxide and forms a 
peroxynitrite which may damage cells [87]. Macrophages do not express iNOS unless 
they are activated by a cytokine or bacterial element such as LPS or IFN-γ. However, 
with reduced L-arginine availability iNOS produces superoxide and peroxynitrite to 
modulate macrophage function such as cytostatic or cytotoxic actions [88].   
NO can easily diffuse across cell membranes and between cells making this the 
perfect intracellular and intercellular signaling molecule [89].  NO was first described by 
Furchgott and Zawadski as an endothelium-dependent relaxing factor for smooth muscles 
[90].  It has been found that NO functions in many more physiological processes that 
originally suspected. Besides acting as an inhibitor to angiotensin II, which is a 
vasoconstrictor, NO inhibits platelet and leukocyte adhesion to the vascular endothelium, 
scavenges superoxide anions, inhibits COX-2 production, and inhibits smooth muscle 
hyperplasia [85]. During chronic inflammation, circulating NO would be increased in an 





 Pharmacological Options for Inflammation 
There are many pharmacological options available for reducing inflammation.  
Two primary categories of anti-inflammatory drugs are the non-steroidal anti-
inflammatory drugs (NSAIDs), which includes the cyclooxygenase inhibitor drugs, and 
the steroidal anti-inflammatory drugs that include glucocorticoids. 
 Non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen and aspirin 
are used primarily to treat inflammation, mild to moderate pain, and fever. Aspirin is 
used to prevent blood clots, strokes, and heart attacks in high-risk individuals [91]. 
Aspirin has also been shown to significantly decrease the progression of atherosclerosis 
in rabbits [92], apoE(-/-) LDLR(-/-) mice [93], diabetic patients [94], and healthy women 
and men [95]. 
  NSAIDs are also included in many cold and flu preparations [96]. NSAIDs 
block the production of prostaglandins by inhibiting COX-1 and COX-2 which is 
responsible for inflammation, pain, fever, and platelet function.  COX-1 is an enzyme 
which is normally present in a variety of tissues in the body, particularly the stomach and 
is also present in sites of inflammation. COX-1 produces some prostaglandins that protect 
the inner lining of the stomach. COX-2, on the other hand, is located specifically in areas 
of the body that commonly are involved in inflammation but not in the stomach. 
Common NSAIDs such as aspirin block both COX-1 and COX-2. Blocking the COX-1 
enzyme reduces inflammation but can also damage the lining of the stomach [14].  COX-
2 specific NSAIDs can reduce inflammation without the risk of injuring the stomach or 
intestines [96]. 
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 Steroidal anti-inflammatory drugs include the glucocorticoids such as 
hydrocortisone, prednisone and dexamethasone. Glucocorticoids have been shown to 
successfully reduce inflammation by repressing the production of pro-inflammatory 
cytokines, chemokines, adhesion molecules, tissue factor, enzymes, and nitric oxide.  If 
not for the debilitating side effects, like osteoporosis, diabetes, cataracts, hypertension, 
thinning of the skin, and even arrested growth [97], it would be the perfect anti-
inflammatory agent.  
Glucocorticoid acts as ligand that binds with glucocorticoid receptors (GR) found 
in the cytosol. GR can regulate its target genes in either a positive or negative way. 
Positive regulation is mainly mediated by direct binding of ligand-activated 
homodimerized GR onto inducible enhancer elements in the gene promoter, called 
glucocorticoid response elements (GREs) [98, 99]. Negative regulation of the 
glucocorticoid dimer creates transcriptional interference with NF-κB which is responsible 
for translation of pro-inflammatory cytokines and other inflammatory molecules and 
activator protein-1 (AP-1). These molecules control a number of cellular processes 
including differentiation, proliferation, and apoptosis [97, 99].  
 
Bioactive Components in Grapes  
 Grapes (Vitis sp.) are a common fruit found worldwide, although, they prefer a 
Mediteranean type climate. Grapes can be eaten fresh, dried as raisins, processed into 
grape juice, or fermented into wine. Nutritional analyses show that grapes are primarily 
sugar and water (81.3%) with very small amounts of fats, proteins, vitamins, and 
minerals [100] (Table 1).  The most notable vitamin and mineral are vitamin K and  
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Table 1:  Nutritional Analysis for Raw, American Type Grapes (USDA, 2005).  
Nutrient Unit Amount/100g 
Carbohydrate g 17.2 
 Dietary Fiber g 0.9 
Fat g 0.33 
Protein g 0.66 
Vitamin A IU 100 
Vitamin C mg 4 
Vitamin E mg 0.22 
Vitamin K mcg 14.57 
Thiamin mg 0.11 
Riboflavin mg 0.11 
Niacin mg 0.33 
Folate mcg 4.02 
Calcium mg 14 
Iron mg 0.33 
Magnesium mg 5 
Phosphorous mg 10 
Potassium mg 191.3 
Sodium mg 1.96 












manganese which supply 17 and 33% of daily value, respectively [100].  Vitamin K has 
been shown to improve insulin sensitivity through suppression of inflammation [101] and 
manganese has been found  to be beneficial in atherosclerosis, diabetes, obesity, and 
cancer by its superoxide dismutase activity [102-104].  
In addition to the vitamin and mineral content of grapes, the health benefits of 
grapes are attributed to its phenolic content [105-114]. Phenolic compounds are 
chemicals produced in plants responsible for their color, odor, and protective qualities.  
Approximately one thousand polyphenols have been identified and many more remain 
unidentified [115]. The majority of polyphenols are usually linked with a sugar, most 
commonly glucose, but may also be linked with any monosaccharide, disaccharide, or 
polysaccharide.   
Dietary polyphenols can be classified into flavonoids and phenolics acids. The 
flavonoids can be classified as flavonols (quercetin, kaempferol, myricetin), flavones 
(luteolin, apigenin), isoflavones (daidzein, genistein), flavanones (hesperetin, 
naringenin), flavanols which has the monomer class catechins (catechin, epicatechin, 
gallocatechin) and polymer class proanthocyanidins (procyanidins, prodelphinidins), and 
the anthocyanins (cyanidin, delphinidin).  The phenolic acids are cinnamic acid (caffeic 
acid, ferulic acid, chlorogenic acid), benzoic acid (gallic acid), and ellagitannin 
(casuarictin, sanguine H6).  
Some of the most extensively investigated polyphenols are resveratrol, 
flavonoids, anthocyanins, and procyanidins. Prior et al. [115, 116] has shown that there is 
a vast difference in the amount of polyphenols in different fruits and vegetables. For 
example, the total phenolic concentration of a grape may be 2000 µg/ml while that of an 
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apple is only 710 µg/ml [117]. A majority of the polyphenols have anti-oxidant properties 
which greatly aid in alleviating chronic inflammation.  Polyphenols also function to 
inhibit the communication between cells and inhibit the binding of proteins to their 
receptors [32]. The phenolic composition of grapes varies with each part of the grape 
(Table 2) [111, 118].  For instance, the purple or red pigmentation in the skins is known 
to possess high concentrations of anthocyanin, resveratrol, quercetin, and flavonoids 
[118].  The grape seeds contain a high concentration of proanthocyanidins [119-121] 
while the pulp is rich in flavan-3-ols [122]. Once processed into wine, red wine is more 
abundant in phenolic compounds such as trans-resveratrol, quercetin, catechin and 
epicatechin [33, 105, 107] and white wine has primarily tyrosol, hydroxytyrosol [123] 
and caffeic acid [124]. 
Besides differences in the part of the grape, polyphenols differ from one variety to 
the next [125, 126]. The total phenolic and anthocyanin content of Cabernet Franc, 
Cabernet Sauvignon, and Merlot were reported to be 4246 and 587 µg/ml [126], 2348 
µg/ml and 990.8 mg/kg, and 2329 µg/ml and 1048.8 mg/kg [125], respectively. An even 
greater difference is noted between the red and white varieties. For example, 
Chardonnay, a white grape variety, compared to Cabernet Franc, a red grape variety, has 
a phenolic concentration of 2011 compared to 4246 µg/ml. The anthocyanin content of 
Chardonnay was undetectable while the Cabernet Franc contained 587 µg/ml [126].  
Growing conditions can also affect the phenolic content of grapes. Price and 
colleagues [127] reported that wines made from Pinot Noir clusters highly exposed to the 
sun had 60% higher anthocyanin concentration than wines from shaded clusters and 14% 
more than wines from moderately exposed clusters. Polyphenolic content can also be  
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Table 2:  Polyphenol Composition of Grapes and Grape Products111,117 
Product Main Polyphenols 
Grapes Anthocyanidins (red grapes) 







Grape juice Anthocyanins (red grape juice) 
 Flavan-3-ols (white grape juice) 
 Ellagic acid 
Grape skin Prodelphinidins 
Resveratrol 
Anthocyanins 
Grape seeds Procyanidins 
Proanthocyanidins 
Grape pulp Flavan-3-ols 
Grape pomace Anthocyanins 
Polyphenol extract Anthocyanidin-3-glucosides 
  
 29
different between growing seasons and harvest time [36, 37, 128].  For example, Mazza 
and colleagues [128] took samples of grapes every week from September to October for 
two consecutive years and assessed the phenolic content of the skin. The concentration of 
total phenolics, flavonoid, and anthocyanin were assessed for three varieties of grapes:  
Cabernet Franc, Merlot, and Pinot Noir. The flavonoid concentration remained constant 
between the two years, but there was up to 25% difference in the total phenolic 
concentration and up to 10% difference in anthocyanin concentration. 
 
Anti-Inflammatory Properties of Grapes 
Research on grapes reviewed in this section is divided whether it is an in vitro 
study, using animal models or done in humans.  Further subdivision was also done 
according to the effects of grape products on platelet aggregation, oxidative stress, foam 
cell formation, inflammatory markers, and other effects. Grape products included in this 
literature review were juice, wine, extract, resveratrol, and proanthocyanidin. 
 
In vitro Studies   
Oxidative Stress 
The efficiency for preventing the oxidation of polyunsaturated fatty acids (PUFA) 
by resveratrol (3,4’,5,trihydroxystilbene) and several flavonoids was compared to that of 
a wine extract containing proanthocyanidins [129]. Low-density lipoproteins (LDL) 
isolated from fresh pig blood was labelled with gold and fluorescein isothiocyanate 
(FITC) then oxidized in the presence or absence of a specific flavonoid (trans-resveratrol, 
quercetin, catechin, epicatechin, or trolox) or wine extract.  Resveratrol was more 
 30
efficient than the flavonoids in preventing copper-induced and induced oxidation of 
PUFA. Moreover, resveratrol was more effective than flavonoids as a chelator of copper 
and less effective as a free-radical scavenger [129].  
 
Inflammatory Markers 
Shanmugam and colleagues [130] compared the extract from twenty-nine plants 
including grape seeds on NO and TNF-α production.  RAW264.7 macrophages were 
activated with LPS and treated with the different plant extracts. Grape seed, along with 
bearberry, were among the most active in inhibiting both NO and TNF-α production 
[131].  Other plants with high polyphenolic content such as chamomile, echinacea, sage 
and valerian were unable to inhibit NO production indicating that polyphenolics have 
their own specific effects. These investigators [131] identified three structural criterion 
important in the anti-inflammatory activity of polyphenolics compounds (i) flavonoid 
aglycones are more potent than the corresponding glycosides, (ii) flavonoids with a 4’-
OH substitution in the B-ring are more potent than those with a 3’-OH-4’-methoxy 
substitution, and (iii) flavonoids of the flavone type (with a C2=C3 double bond) are 
more potent than those of the flavanone type (with a at C2-C3 single bond).  
The effect of Muscadine grapes skin extract on the release of cytokines by LPS-
activated peripheral blood mononuclear cells, and the production of superoxide free 
radicals in phorbol myristate acetate-activated neutrophils was investigated by Greenspan 
and colleagues [132]. Muscadine grapes are native to the southeastern U.S. states and 
have been shown to be extremely high in anti-oxidant activity [133-135] yet, little 
research has been done with them.  The phenolic and ellagic acid content of the 
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Muscadine grape skin extract used in the study by Greenspan and colleagues [132] was 
2.1 mg/ml and 67 µg/ml, respectively. Diluted Muscadine skin extract inhibited TNF-α 
and IL-6 production by nearly 50%. The same dilution of the extract also inhibited 
superoxide production from neutrophils by 65%, an effect that is comparable to the 
positive control aspirin [132].  A more dilute solution of muscadine grape extract (1:400) 
inhibited IL-1β production by approximately 60% but TNF-α and IL-6 production were 
not affected. These results show that some component of Muscadine grape skin extract 
may have anti-inflammatory properties.  
The effect of grape seed proanthocyanidin extract (monomer, dimers, trimers) on 
the production of pro-inflammatory molecules PGE2 and NO was compared with 
different anti-inflammatory agents (aspirin, indomethacin, and dexamethasone) and pure 
phenolic fractions (catechin and epicatechin) [136]. Proanthocyanidins, also known as 
condensed tannins or oligomers or polymers of flavan-3-ol units are found in abundance 
in grape seeds [137].  NO and PGE2 production were assessed in RAW 264.7 murine 
macrophages stimulated with LPS and IFN-γ to induce an inflammatory response. 
Proanthocyanidin extract inhibited NO and PGE2 in a dose and time-dependent manner. 
The greatest inhibition of NO and PGE2 occurred when the extract was incubated 
simultaneously with LPS and IFN-γ.  Epicatechin and catechin did not exert any 
significant inhibition on NO production.  Although PGE2 was inhibited by the 
proanthocyanidins extract, the highest inhibition of PGE2 was accomplished with the 
anti-inflammatory drugs, aspirin and indomethacin.  They also found that increased 
polymerization of the proanthocyanidins increased the inhibitory effect [132]. These 
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findings indicate that not only does the type but also the polymerization of the phenolic 
compounds influence anti-inflammatory properties of grape proanthocyanidins. 
Another study on grape seed proanthocyanidins extract investigated its effect on 
intracellular adhesion molecule (ICAM-1) and vascular cell adhesion molecule (VCAM-
1) expression in primary human umbilical vein endothelial cells induced by TNF-α [138].  
Grape seed proanthocyanidin extract down regulated VCAM-1, but not ICAM-1 
expression [138]. The regulation of VCAM-1 expression by grape seed proanthocyanidin 
extract was at the transcriptional or post-transcriptional level and not through NF-κB 
pathway indicating that another mechanism is involved in the regulation of transcription 
of VCAM-1.  
Resveratrol, a phenolic compound found in grapes and grape products has been 
shown to have anti-inflammatory properties [139].  Holmes-McNary and colleagues 
[139] tested whether resveratrol could modulate NF-κB activity, a factor involved in the 
inflammatory process. Human monocyte (THP-1) and macrophage (U937) cell lines were 
treated with purified trans-resveratrol and stimulated with either TNF or LPS. 
Resveratrol was effective in blocking IKK activation hindering the DNA binding activity 
of NF-κB, thereby blocking production of inflammatory cytokines [139]. 
Based on the reported anti-inflammatory activity of resveratrol, Xiu Li Bi and 
colleagues [140] investigated the effect of resveratrol in inhibiting activation of 
proinflammatory molecules such as NO and TNF-α in microglia (the macrophage in the 
central nervous system). Murine microglial cell line N9 was treated with resveratrol and 
stimulated with LPS.  NO and TNF-α production were both inhibited by resveratrol. LPS 
increased IκBα degradation while resveratrol inhibited the degradation of IκBα, resulting 
 33
in decreased production of NO and TNF-α [140]. This study demonstrates that resveratrol 
inhibits inflammation at the transcriptional level by reducing the degradation of IκBα. 
 
Other Effects 
Concord grape seed extract was used to determine its effect on relaxation of 
endothelium [141]. Rat aortic rings with intact endothelial lining were treated with 1μM 
phenylephrine causing the endothelium to contract.  Several fractions of Concord grape 
seed extract were compared against acetylcholine in relaxing the endothelium. Fraction A 
(gallic acid), fraction B (catechin and epicatechin), and fraction C (epicatechin gallate 
and flavan-3-ol) displayed very little activity. Fractions D-G (containing various dimers, 
trimers, tetramers, and pentamers of proanthocyanidin) displayed significantly more 
activity. This experiment demonstrates that proanthocyanidins are the primary component 
of grape seed extract responsible for endothelial relaxation [141]. 
The effect of resveratrol on chemotaxis was investigated using human peripheral 
blood phagocytes and rat basophilic leukemia cell line (RBL-2H3) transfected with 
epitope-tagged human FPR (ETFR) cells. The cells were treated with resveratrol and 
incubated with various chemokines that are responsible for attracting phagocytic 
lymphocytes to the site of inflammation. Chemoattraction with all of the chemokines was 
inhibited as the concentration of resveratrol increased [142]. Resveratrol reduced 
phosphorylation of extracellular signal-regulated kinase (ERK1/2) and the activation of 
nuclear factor NF-κB induced by formylpeptide receptor agonists. These results suggest 
that resveratrol may inhibit the function of chemoattractant receptors contributing to the 






 A study by Shanmuganayagam and colleagues [143] was done to determine the 
effects of phenolic extract from grape seeds or grape skin alone or in combination with an 
enzyme blend in inhibiting platelet aggregation. Four classes of phenolic compounds 
(hydroxycinnamic acids, flavonols, anthocyanins, and polygalloyl polyflavan-3-ol) were 
found to be present in the grape skin extract and one (polygalloyl polyflavan-3-ol) in 
grape seed extract [143].  Seven dogs were given one of the following treatments:  grape 
skin extract, grape seed extract, an enzyme blend, a combination of the two extracts, and 
the two extracts plus the enzyme blend for seven days followed by a seven day washout. 
Individually, the extracts and the enzyme blend had no effect on platelet aggregation. 
However, the grape extract with the enzyme blend worked synergistically to significantly 
inhibit platelet aggregation. Addition of the enzyme blend to the grape extract doubled 
the effectiveness in inhibiting platelet aggregation. Moreover, the combination of grape 
extract with the enzyme blend inhibited platelet aggregation for at least 24 hours after the 
final dose.  Grape seed and grape skin extracts have little or no effect on platelet activity 
when used individually but elicit a greater anti-platelet effect when used in combination 
with an enzyme blend [143].  
Another study by Shanmuganayagam and colleagues [144] investigated if the 
polyphenols of Concord grape juice would inhibit platelet aggregation in rabbits fed a 
hypercholesterolemic diet. Grape juice and a control of sugar water were given ad libitum 
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for 96 days. A significant  decrease in platelet aggregation was observed in the grape 
juice treatment as well as significantly lower atheroma development, total serum 
cholesterol, and blood pressure [144].  
The effect of red wine, white wine, or grape juice on platelet inhibition was 
investigated in dogs [145]. Cyclic flow reductions (CFRs) caused by platelet-mediated 
thrombi were measured as dogs were treated intraveneously and intragastrically with 
diluted red or white wine (2 and 4 ml/kg), or Concord grape juice (4, 6, 8, and 10 ml/kg) 
until the CFRs ended. Blood aggregation was compared before and after beverage 
administration using a whole blood aggregometer.  Platelet aggregation was successfully 
diminished with red wine and grape juice but not with the white wine. A blood alcohol 
content (BAC) of 0.2 g/dl is usually required to inhibit platelet aggregation but the BAC 
of the dogs after administration of the wine was only 0.028 g/dl suggesting that other 
compounds present in red wine and grape juice, absent in white wine were responsible 
for the improved coronary blood flow [145].  Grape juice reduced platelet aggregation in 
a dose-dependent manner, although, approximately two and half times higher dose of 
grape juice was needed compared to the wine to inhibit platelet aggregation.  A similar 
study by Ruf and colleagues [146] also demonstrated improved coronary blood flow in 
rats treated with dilute red wine for four months in comparison to  white wine and ethanol 
[147]. 
A study by Osman and colleagues [148] compared the effect of three fruit juices 
(grapes, orange, and grapefruit) on platelet aggregation. Five monkeys were fed grape 
juice, orange juice, and grapefruit juice (5 mL/kg) for 7 days in a cross-over design. 
Grape juice reduced the amount of platelet aggregation while there was no difference in 
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the orange juice and grapefruit juice [148]. The investigators concluded that although 
orange and grapefruit juices contain many phenolics compounds, they do not contain the 
phenolic compounds responsible for reduction of platelet aggregation. 
 
Lipid Profile and Oxidative Stress 
A study by Rodrigo and colleagues [149] compared the effects of red wine to that 
of water, ethanol, or alcohol-free red wine on oxidative stress. Rats were given the 
corresponding treatments for ten weeks. Red wine or alcohol-free wine exhibited lower 
oxidative stress as indicated by the increased ferric reducing ability of plasma (FRAP) 
assay [149]. However, a study by Cestaro and colleagues (1996) showed that oxidative 
status does not appear seriously altered by ingestion of wine and polyphenols. The 
researchers suggest that the balanced diet and adequate intake of micronutrients were 
sufficient to counteract any oxidative damage [150].  
 The effects of grape products on oxidative stress, lipid profile, glucose, and blood 
pressure have also been investigated by Araya and colleagues [151]. They demonstrated 
that red wine rich in flavonols, ethanol (125 ml/l), and alcohol-free red wine increased 
blood HDL and triacylglycerols but it did not affect overall lipid profile compared to 
water.  The red wine and alcohol-free red wine also increased FRAP values indicating 
greater anti-oxidative power [151].  
Falchi et al [118] compared the effect of grape skin or flesh on oxidative stress. 
Rats were fed water as the control and grape skin or grape flesh for 30 days after which 
induced myocardial infarct size on the excised heart and malonaldehyde were assessed to 
determine oxidative stress. The flesh of grapes is equally cardioprotective as the skin as 
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indicated by the significantly improved aortic flow during reperfusion of the heart and the 
reduction of the infarct size in comparison to the control. The antioxidant potential of the 
skin and flesh of grapes are comparable with each other despite the fact that flesh does 
not possess any anthocyanin [118]. 
 Cui and colleagues [111] investigated the dose-dependent effect of a standardized 
grape extract preparation on aortic flow, amount of myocardial infarction on the excised 
heart, and oxidative stress indicated by malonaldehyde content. Male Sprague-Dawley 
rats were given a standardized grape extract at 50, 100, or 200 mg/kg body weight per 
day for 3 weeks. Significant cardioprotection as indicated by greater aortic flow and a 
reduced amount of myocardial infarction and malonaldehyde concentration in the heart 
was induced by the 100 mg/kg and 200 mg/kg standardized grape extract.  The lowest 
concentration of standardized grape extract (50 mg/kg) did not exhibit any 
cardioprotective effects [111].  
Cui and colleagues [112] used the same model in determining whether white wine 
had any cardioprotective effect as indicated by malonaldehyde content. Extracts prepared 
from three different white wines from Italy (Verduzzo Friulano Isonzo, Tocai Friulano 
Collio, and Passito di Tocai Friulano Collio) were given to rats at either 50 mg/kg or 100 
mg/kg dose. Comparison of the white wine with the control showed so significant effects 
[112].  The phenolic compounds found in red wine and grapes are more cardioprotective 
than white wine phenolic compounds. 
The effects of grape seed polyphenol (GSP) on serum and hepatic lipid contents 
and on fecal steroid excretion were investigated by Nakamura and colleagues [152]. GSP 
was given orally at doses of 0.01-1.0 g/kg per day to normal rats and 
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hypercholesterolemic rats for 30 days.  Their findings indicate that the GSP lowered the 
concentrations of serum and hepatic triglycerides rather than altering the metabolism of 
cholesterol [152]. 
Martin-Carron and colleagues [153] evaluated the effects of dietary fiber and 
polyphenol content from red and white grape peels and white grape seeds (100 g/kg) on 
lipid profile as well as on body weight, fat, and protein digestibility. Adult Wistar rats 
were fed cholesterol-free and cholesterol-added diets containing cellulose as a control or 
the test material for 42 days. Dietary fiber content of materials ranged from 540 to 590 
g/kg.  Intake of grape products increased stool weight and the amount of fat and protein 
excreted in feces, but did not affect growth or protein efficiency of the diet.  All of the 
grape fractions lowered serum total cholesterol and LDL cholesterol concentrations in 
rats fed cholesterol diets [153]. 
The effect of grape pomace on serum and tissue cholesterol were compared to that 
of tomato and apple pomace [154]. Male Wistar rats were fed a cholesterol diet (0.3%) 
shortly after weaning continuing for 10 weeks with diets supplemented with the test 
material (5% in diet). None of the tested products affected serum cholesterol 
concentration.  However, tomato and apple pomace significantly reduced cholesterol 
levels in the liver by 15% and 11%, respectively. All tested pomace reduced cholesterol 
content of the heart by approximately 20%. Triacylglycerol concentration was affected 
only by tomato pomace and solely in the heart.  Cholesterol absorption measured by dual-
isotope ratio method was not significantly affected by the pomace; however, all products 
strongly reduced the activity of HMG-CoA reductase in liver and increased the fractional 
catabolic rate of plasma cholesterol.  All tested pomace reduced plasma levels of 
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conjugated dienes and tomato and grape pomace exhibited this effect also in the liver.  
All tested pomace reduced the activities of antioxidant enzymes superoxide dismutase, 
catalase and glutathione peroxidase in erythrocytes (by 34-56%) [154]. These results 




 Li and colleagues [155] investigated whether grape seed proanthocyanidin can 
reduce swelling in croton oil-induced ear swelling in mice and carrageenan-induced hind 
paw edema in rats. Mice were injected with proanthocyanidins (10, 20, 40 mg/kg) or 
dextrose (2 mg/kg) thirty minutes before edema was induced. The edema extent was 
expressed as the weight difference between the inflamed and the control. The paws of the 
rats were treated in the same manner. Paw thickness was measured before and up to 12 
hours after inflammation induction. The paw and exudate were harvested for 
measurement of pro-inflammatory molecules. Grape proanthocyanidins dose-dependently 
reduced swelling and inflammatory markers (NO, malondialdehyde, IL-1β, TNF-α, and 
PGE2) in this animal model [121].  
Terra and colleagues [156] used a rat model to investigate the effect of grape 
procyanidins in combination with high fat diet on inflammatory markers. The 
inflammatory markers, CRP, IL-6 and TNF-α increased with the high fat diet and 
diminished with grape procyanidins treatment. The anti-inflammatory cytokine, 
adiponectin, is decreased in the rats fed the high fat diet and significantly increased in the 
rats treated with procyanidins [156]. Procyanidin treatment may be beneficial in 
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increasing the adiponectin production and in reducing chronic inflammation in rats fed a 
high fat diet. 
Another phenolic compound of grapes that has been investigated for their anti-
inflammatory properties is piceatannol [157].  Piceatannol is a polyphenol found in 
grapes that acts as a protein kinase inhibitor which modifies multiple cellular targets 
including TNF-induced NF-κB inhibition [158]. Kim et al [157] investigated the effect of 
piceatannol in BALB/c mice given dextran sulfate sodium (DSS) in their water (control 
group received water only) to induce colitis. The DSS treated mice had higher plasma 
concentrations of NO and PGE2 , however, treatment with the piceatannol reduced 
production of NO and PGE2 in a dose-dependent manner. Similarly, DSS treatment 
significantly increased plasma concentrations of the inflammatory cytokines IL-1β, IL-6, 
and TNF-α and treatment with piceatannol (10mg/kg) inhibited cytokine production in 
this animal model. mRNA levels for iNOS and COX-2 were significantly induced by 
DSS, and again, reduced by treatment with piceatannol.  This experiment demonstrates 
that individual components of grapes are potent anti-inflammatory agents [157].   
 
Other Effects 
The effects of two red wine polyphenol compounds on blood pressure were 
investigated by Diebolt and colleagues [159].  Two powder preparations of red wine 
polyphenol were given to rats intragastrically (20 mg/kg) for 7 days. Blood pressure 
dropped significantly on the 4th day after administration of both powders.  This 
hemodynamic effect was associated with an enhanced endothelium-dependent relaxation 
and an induction of gene expression of inducible NO synthase and COX-2 within the 
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arterial wall [159]. In another study, red wine polyphenol powder fed to rats was shown 
to accelerate the decrease of blood pressure and improve structural and functional 
cardiovascular changes produced by chronic inhibition of NO synthesis created by 
administration of N-nitro-L-arginine methyl ester (L-NAME) [108].  
Resveratrol has been shown to stimulate NO synthetase activity and reduce blood 
pressure in hypertensive female rats [160].  Resveratrol was shown to reduce blood 




The inhibitory effect of grape juice on platelet aggregation was studied by Keevil 
and colleagues [163]. Ten healthy participants were asked to consume 5-7.5 ml/kg per 
day of either purple grape, orange, or grapefruit juice in a randomized cross-over design.  
A 66% decrease in aggregation was observed after a week of drinking purple grape juice 
whereas there was no change after drinking orange or grapefruit juice [163].  The 
observed effect on platelet aggregation by the different juices may be due to differences 
in the content of phenolic compounds. Purple grape juice had a total polyphenolic 
concentration of almost three times that of orange or grapefruit juice (2.26, 0.75 and 0.86 
g/L, respectively). This is a clear demonstration that the amount and class of polyphenols 
present in the fruit juice are responsible for the reduction of platelet aggregation. 
Pace-Asciak and colleagues [164] investigated the effects of different grape 
beverages on platelet aggregation. Red wine, white wine, purple grape juice and purple 
grape juice supplemented with resveratrol were given to 24 healthy male participants for 
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a 2-week period. Red wine did not have an advantage over the white wine and the grape 
juice supplemented with resveratrol did not significantly reduce platelet aggregation in 
comparison to the commercial grape juice. These findings suggest that the dominant anti-
aggregatory component in the beverages may have been dominated by the alcohol rather 
than the resveratrol [164].  
Freedman and colleagues [165] also compared the effects of purple grape juice 
polyphenols on platelet aggregation, nitric oxide, and superoxide production.  This study 
used 20 healthy participants who consumed 7 mL/kg per day of purple grape juice for 14 
days. Purple grape juice significantly reduced platelet aggregation and superoxide 
production, but increased the release of NO [165]. These results show that purple grape 




A study by O’Bryne and colleagues [166] compared the antioxidant properties of 
Concord grapes to α-tocopherol.  Participants received either α-tocopherol (400 IU/day) 
or Concord grape juice (10 ml/day) for two weeks. Concord grape juice and α-tocopherol 
increased serum antioxidant capacity and protected LDL against oxidation. However, 
Concord grape juice decreased native plasma protein oxidation significantly more than 
did α-tocopherol. Concord grape juice was shown to protect against oxidative stress and 
reduce the risk of free radical damage in healthy adults by reducing the concentration of 




Badia and colleagues [167] investigated the effect of two alcoholic beverages 
with high (red wine) or low (gin) polyphenolic content on TNF-α induced adhesion of 
human monocytes to endothelial cell. A randomized, crossover trial was conducted with 
eight healthy men who received 30 g ethanol/d as red wine or gin for 28 days. TNF-α 
induced adhesion of monocytes to endothelial cells was virtually abolished after red wine 
consumption but was only partially reduced after gin consumption [167]. Both beverages 
showed anti-inflammatory effects by reducing plasma fibrinogen and IL-1 levels. 
However, wine had the additional effect of decreasing high sensitivity C-reactive protein 
(hs-CRP), as well as monocyte and endothelial adhesion molecules [168].  While the 
alcohol is responsible for part of the anti-inflammatory effect, the polyphenols in the 
wine are much more effective in decreasing markers of inflammation. 
A similar study investigated the effect of wine on lipid and inflammatory markers 
in healthy women [169].  In a cross-over study, thirty-five healthy women were given red 
wine or white wine with an equivalent of 20 g ethanol/d for 4 weeks. Serum HDL 
cholesterol increased while serum concentration of hsCRP, intercellular adhesion 
molecule-1, CD40L, and IL-6 decreased after either wine. Enhanced adhesion of 
monocytes to stimulated endothelial cells was reduced by 51% and 89% after 
consumption of white and red wine, respectively [169]. The findings of this study show 
that moderate wine consumption is associated with beneficial effects on various 
inflammatory pathways related to endothelial activation in healthy women. 
The effect of wine was also investigated in men with angiographically-proven 
coronary artery disease [170]. Thirteen men consumed 2 to 3 glasses (4 mL/kg) of red 
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wine or white wine during a meal in a random cross-over design.  Moderate wine intake 
acutely increased plasma levels of IL-6 in men with coronary artery disease. The 
researchers suggested that the increase in plasma IL-6 is a response to alcohol-induced 
oxidative stress in the liver [170]. There was no difference in the acute response between 
red wine and white wine. This suggests that the alcohol portion of the wine creates an 
inflammatory response in the liver of already compromised individuals but can be a 
preventative treatment for healthy individuals.  
Castilla and colleagues [171, 172] conducted several studies on the effect of grape 
juice on the risk of cardiovascular disease in hemodialysis patients.  In the first study, 
hemodialysis patients and healthy subjects were instructed to drink concentrated red 
grape juice (100 ml/d) daily for 14 days.  The findings of their first study showed that red 
grape juice given to hemodialysis patients improved lipoprotein profile, reduced plasma 
concentrations of MCP-1 and oxidized LDL (oxLDL), and may favor a reduction in 
cardiovascular disease risk in this population [172]. In the second study, the effect on 
lipid profile of red grape juice was compared to that of vitamin E [171]. Thirty-two 
patients undergoing hemodialysis were divided into four groups:  red grape juice (100 
ml/day), vitamin E (800 IU), both, or the control (neither supplement nor placebo).  Red 
grape juice, but not vitamin E, reduced plasma concentrations of total cholesterol and 
apo-b and increased HDL cholesterol concentrations. Both red grape juice and vitamin E 
reduced plasma concentrations of oxLDL and ex vivo neutrophil NADPH oxidase activity 
[171]. Regular ingestion of concentrated red grape juice by hemodialysis patients reduced 
neutrophil NADPH-oxidase activity and plasma concentrations of oxidized LDL and 
inflammatory biomarkers to a greater extent than vitamin E. This effect of red grape juice 
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consumption may favor a reduction in cardiovascular risk by alleviating atherosclerosis 
induced by oxidized LDL. Vitamin E is effective in reducing oxidative stress but did not 
influence the concentration of plasma cholesterol. However, red grape juice influenced 
both oxidative stress and plasma cholesterol making it more cardioprotective than 
vitamin E. 
Renaud and colleagues [173] investigated the correlation of wine consumption 
and the rate of death from coronary artery disease. Thirty six thousand five hundred and 
eighty three middle-aged healthy men participated by completing an extensive 
questionnaire on alcohol use and a physical examination to determine the effect of 
beverage on coronary artery disease. Death due to coronary artery disease was monitored 
for over twenty years. Moderate wine drinkers had a significantly lower death rate than 
heavy wine drinkers and men that drank other types of alcoholic beverages [173].  
 
 
Oklahoma Grapes   
Grapes have been an important part of Oklahoma’s history even before it was a 
state. Vitis doaniana, a wild grape named after winemaker Judge J. Doan, grew 
abundantly in the Indian Territory. In 1890, a year after the territory was opened to 
settlers, Edward Fairchild, a winemaker from New York, bought land near Oklahoma 
City for a vineyard and orchard [174]. Fairchild successfully grew Concord and Delaware 
grapes to make his wine until Oklahoma became a state in 1907.  Oklahoma joined the 
union as a dry state thereby halting wine production [174]. Yet, in the 1910 census, 
Oklahoma reported over 4000 acres of vineyards, ranking it eighth in the nation in grape 
production. Thomas Volney Munson, a nurseryman, grape hybridizer, and ampelographer 
declared Oklahoma as a splendid grape-growing region [174]. Grape growing in 
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Oklahoma is becoming more widespread as researchers release hybrid varieties with 
desirable fruit characteristics: vine vigor, disease resistance, productivity, drought 
resistance, cold hardiness, and fruit acceptability for juice, jelly, table use, and wine 
[175].  
In recent years, there has been an increase in grape production in Oklahoma. 
While approximately 170 acres of grapes were grown in Oklahoma in 1997, that number 
grew to 375 acres in 2002 and 525 acres in 2005.  In 2007, the state boasted over fifty 
licensed wineries up from just four wineries six years earlier [176]. Small wineries also 
generate annual sales between $200,000 and $1.5 million, create employment, and spur 
the economic development of the surrounding area [177]. Yet, even though Oklahoma is 
a splendid grape growing area, development of hardier, disease-resistant varieties is vital 
to the industry. 
 Most grape varieties currently being grown in Oklahoma originated in Europe. 
Cross-breeding of grapes became necessary because V.  vinifera, which originated in the 
Caspian Sea region, required a long growing season with relatively high summer 
temperatures, low humidity, a rain-free harvest period, and mild winter temperatures 
[178]. Not only was the growing season not suitable for other areas, but this European 
species was also susceptible to numerous afflictions such as insects, fungus, and viral and 
bacterial infections.  
During the many failed attempts to introduce varieties of V. vinifera to North 
America, some of the V. vinifera naturally crossed with native varieties such as fox grape 
(V. labrusca), the riverbank grape (V. riparia), and the scuppernong (V. rotundifolia) to 
create varieties that would thrive on the North American continent [179]. The post oak 
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grape (V.lincecumii) is native to Oklahoma and surrounding states. This grape was hailed 
by Munson as being especially important for creating hybrid grape varieties [178]. 
Meanwhile, many of the world varieties of the European species must be grafted onto 
rootstocks of North American species to prevent devastation by the phylloxera root louse. 
Rubaiyat is one of many varieties of grapes developed by Herman Hinrichs at 
Oklahoma State University. This variety was developed in 1952 as a cross between 
Seibel 5437 and Bailey.  The overall genetic constitution of Rubaiyat is 37.5% V. 
lincecumii, 31.25% V. vinifera, 18.75% V. labrusca, 6.25% V. rupestris, and 6.25% V. 
riparia. Some characteristics of Rubaiyat include its medium vigor, medium cluster size, 
large berry size, disease resistance, cold hardiness, and usefulness as a teinturier (add 
color in blends)[178].  
The increasing trend in Oklahoma towards grape production has sparked the need 
to understand the health benefits associated with grapes grown locally, including their 
anti-inflammatory properties. Increased knowledge of the health benefits of grapes may 
further help growers to promote their products and increase their consumption which will 
help Oklahoma’s viticulture and agritourism business.  
In this study we will investigate the concentration of total phenolic, flavonoids, 
and anthocyanins found in thirty-three varieties of grapes grown at the Cimarron Valley 
Research Station in Perkins, Oklahoma. The oxidative potential will then be measured to 
determine if the grape juice has anti-oxidative properties and in vitro investigation with 
LPS-induced RAW264.7 murine macrophage to see the effects of treatment with the 
juice on NO production.  From this data, ten varieties were chosen for further analysis as 
extract.  The concentration of extract for the maximum inhibition of NO will be 
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determined with LPS-induced macrophages. And finally, one variety with high total 
phenolic content and greatest inhibitory effects was chosen to compare against 
Resveratrol in production and expression of COX-2, IL-6, iNOS, and TNF-α which are 
markers of inflammation. The results indicate the cardioprotective properties of grapes by 
the ability to reduce NO, TNF-α, and IL-6 production and the reduced expression of 







Specific Aim 1:  To determine the phenolic content, anti-oxidant capacity, and anti-
inflammatory properties of juice from different varieties of grapes grown in Oklahoma. 
 
Grape Juice Preparation 
Thirty-three different varieties of grapes were obtained from the Cimarron Valley 
Research Station (Perkins, OK) at their respective harvest times in 2007 (Table 3). The 
vineyard utilized three different trellis systems; high cordon, Geneva double curtain, and 
vertical shoot positioning system. The trellis system allows for increased control of 
damage by insects and disease. More damage resulted from a spring freeze that occurred 
during budbreak. Varieties with early budbreak such as Cabernet Franc, Chardonnay, 
Viognier, Merlot, and Sangiovese had some damage however it was not significantly 
more than the other varieties. Another source of some damage was a phenoxy herbicide 
drift from an unknown source which damaged mostly the Sunbelt, Cimarron, Cynthiana, 
and Traminette [175]. Upon arrival to the laboratory, the grapes were refrigerated at 4ºC 
for less than 48 hours until processing.  The grapes were washed and air dried at room 
temperature on a paper towel and the stems were removed before preparing the juice.  
Grape juice was prepared two ways:  smashed with a flask in a Buchner funnel or 
pureed in an Oster blender.  Grape juice was then filtered twice in a Buchner funnel with 
No.4 Whatman paper filter, divided into several aliquots, and stored at  -20ºC until 
analysis.  The remaining whole grapes were also frozen at -20ºC for use if necessary.  
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Table 3:  Harvest Time of Grapes used in this Study1 
Variety Harvest Time 
Cabernet Franc September 27, 2007 
Cabernet Sauvignon September 27, 2007 
Chambourcin August 28, 2007 
Chardonel August 17, 2007 
Chardonnay September 13, 2007 
Cimmaron August 23, 2007 
Corot Noir Not Available 
Cynthiana September 4, 2007 
Frontenac August 13, 2007 
Gamay August 28, 2007 
GG 9318 October 9, 2007 
GG 9330 October 9, 2007 
GG 9336 October 9, 2007 
GG 9356 October 9, 2007 
H1 #249 September 5, 2007 
H2 #211 September 5, 2007 
H5 #125 September 5, 2007 
Merlot September 13, 2007 
Montepulciano October 4, 2007 
Petit Verdot September 27, 2007 
Pinot Gris September 13, 2007 
Rubaiyat October 4, 2007 
Ruby Cabernet September 27, 2007 
Sangiovese September 13, 2007 
Sauvignon Blanc August 28, 2007 
Shiraz September 13, 2007 
Sunbelt October 4, 2007 
Traminette August 28, 2007 
Vignoles August 17, 2007 
Villard Blanc Not Available 
Viognier August 23, 2007 
White Riesling August 28, 2007 
Zinfandel October 4, 2007 





Total Phenolic, Anthocyanin, and Flavonoid Content  
The total phenolic content of the juices was determined using the Folin Ciocalteau 
assay [180]. The total phenolic assay utilizes the reaction between Folin-Ciocalteau’s 
reagent and phenol to form a chromogen that can be measured spectrophotometrically. 
Gallic acid (Sigma Aldrich, St. Louis, MO) dissolved in 40% ethanol was used as the  
standard (0-1000 µM). An aliquot of each grape juice or standard solution was mixed 
with Millipore water and Folin-Ciocalteau reagent (Sigma Aldrich, St. Louis, MO). The 
reaction was neutralized with 20% sodium carbonate solution and Millipore water was 
added followed by incubation at room temperature for 2 hours. The absorbance was read 
at 760 nm using a Beckman spectrophotometer (Fullerton, CA).  Total phenolic content 
was calculated from the standard curve and expressed as mg/L gallic acid equivalent. 
  Analysis of flavonoid content was based on the colorimetric assay of Kim and 
colleagues [181]. Catechin dissolved in water was used as the standard (0-200 mg/L).  
Grape juice or standard solution, Millipore water, 5% sodium nitrite solution, 10% 
aluminum chloride solution, and 1M NaOH were mixed in a test tube. The absorbance 
was read at 510 nm using a Beckman spectrophotometer (Fullerton, CA). Flavonoid 
concentration was calculated from the standard curve and results were expressed as 
milligram of catechin equivalents per liter grape juice. 
 Anthocyanin concentration was determined with a modified pH differential 
method also used by Lee and colleagues [182].  Potassium chloride buffer (0.025 M, pH 
1.0) and sodium acetate buffer (0.4 M, pH 4.5) were added to the grape juice. The grape 
juice to buffer ratio was 1:3 and 1:8 for white grapes and purple grapes, respectively. 
Absorbance was read at 510 and 700 nm using the Biotek microplate reader (Synergy, 
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Winooski, VT). Total monomeric anthocyanin content was calculated according to the 
equation:    
Anthocyanin concentration (mg/L) = ∆A x MW x DF x 1000/ (ε x c) 
where ∆A, absorbance = [(A510 – A700) pH1 – (A510 – A700) pH4.5]; MW =  molecular 
weight of anthocyanin (449.2 g/mol) ; DF = dilution factor (1:3 for white grapes, 1:8 for 
purple/red grapes); ε =  molar absorptivity of cyanidin-3-glucoside ( 26,900 L/cm mol); 
and c = cell pathlength (1 cm). 
 
Ferric Reducing Ability (FRA) Assay 
Anti-oxidant capacity was measured by the FRA assay [183]. The working FRA 
reagent was prepared with 300 mM acetate buffer, 10 mM 2, 4, 6-Tris (2-pyridyl)-s-
triazine (TPTZ), and 20 mM FeCl3 in the ratio of 10:1:1. Ferrous sulfate solution (0-500 
µM) was used as standard. Each sample or standard solution and FRA reagent were 
added and mixed in a 96-well plate. Absorbance was read at 593 nm every 2 minutes 
starting at zero up to twenty minutes of mixing time. FRA was calculated according to 
the equation [183]: 
FRA value (µM) = {(0-10min. ∆A593nm sample)/(0-10min.∆A593nm std)} FRAstd (µM) 
where ΔA is the change in absorbance. 
 
 Cell Propagation and Treatment 
 RAW264.7 murine macrophages from American Type Culture Collection 
(Manassas, VA) were grown in Dubelcco’s Modified Eagles Media (DMEM) with 10% 
fetal bovine serum (FBS) (Gibco, Carlsbad, CA), and 1% penicillin/streptomycin (Sigma 
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Aldrich, St. Louis, MO).  The cells were incubated at 37ºC with 5% CO2. After 24 hours, 
the media was replaced with fresh media. The flask was checked with a microscope for 
confluent growth after 48 hours and split into other flasks as needed. 
 Treatment of the cells with grape juice was performed in a 96-well plate 
containing approximately 2.0 X 105 cells/well.  The plates were incubated at 37ºC with 
5% CO2  for 24 hours. Media containing different concentrations of grape juice (0, 1, 5, 
and 10%) were added to the cells which were then incubated at 37ºC with 5% CO2  for 
another 24 hours.  Media containing juice was removed and cells were washed with 
phosphate buffered saline. The cells were then given new media containing 500 ng/ml of 
Escherichia coli lipopolysaccharide (LPS, Serotype 0127:B8, Sigma, St. Louis, MO).  
After 24 hours of LPS treatment, media was collected for assessment of nitric oxide and 




Cell viability was assessed using a commercially available resazurin kit (Sigma 
Aldrich, St. Louis, MO). Resazurin detects cell viability by the conversion of a 
nonfluorescent dye to a highly red fluorescent dye resorufin in response to chemical 
reduction of growth medium resulting from cell growth. Continued cell growth maintains 
a reduced environment while inhibition of growth maintains an oxidized environment. 
Reduction related to growth causes the redox indicator dye to change from the oxidized 
(nonfluorescent, purple color) form to the reduced (fluorescent, red color) form.  
Resazurin solution in cell media (5%) was added into each well and the plate was 
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incubated at 37°C with 5% CO2 for 4 hours.  Absorbance was read at 520 nm using a 
Biotek microplate reader (Synergy, Minooski, VT). Cell viability was expressed as a 
percentage of the control. 
 
Assessment of Nitric Oxide 
 Nitric oxide was measured with the Promega Griess reagent system (Madison, 
WI).  This nitrate kit utilizes a two step process for measurement of total nitrite 
concentration in a sample.  The first step is the conversion of nitrate to nitrite using 
nitrate reductase. The second step is the addition of Griess reagents (sulfanilamide and N-
(1-Napthyl) ethylenediamine (NED)) which converts nitrite into a deep purple azo 
compound.  The intensity of the color is directly proportional to the nitrite concentration. 
 Briefly, nitrate standard solution or samples (cell media collected after grape 
juice and LPS treatment) were pipetted into a 96-well plate. Sulfanilamide solution was 
added to each well and allowed to incubate at room temperature in the dark for 10 
minutes. The NED solution was then added and allowed to incubate for 10 minutes at 
room temperature in the dark.  The absorbance was read within 30 minutes at 520 nm 
using a Biotek microplate reader (Synergy, Winooski, VT). Nitric oxide was calculated 
from the nitrate standard curve. 
  
Specific Aim 2:  To assess the in vitro anti-inflammatory properties of extract from 





Grape Extract Preparation and Analyses 
 Base on the results of Specific Aim 1, ten grape varieties (five varieties with 
relatively high total phenolic content and five varieties with relatively low total phenolic 
content) were chosen (Table 4). Grapes were pureed for one minute in an Oster blender 
with a solution of methanol, ethanol, and water (50:25:25 v:v:v).  The puree was 
sonicated in ice for 30 minutes, and centrifuged for 30 minutes at 10,000 g at 4°C.  The 
supernatant was poured through a 0.45μm filter with vacuum and evaporated (Rotovap, 
BÜCHI, Flawil, Switzerland) to the aqueous fraction.  The aqueous fraction was filtered 
through a C18 (Waters Corp., Milford, MA) column in accordance with the product 
instructions to remove most of the carbohydrates.  The resulting methanol fraction was 
evaporated (Rotovap, BÜCHI, Flawil, Switzerland) to dryness and the remaining extract 
was reconstituted with sterile water.  The extract was aliquoted and frozen at -80°C until 
needed for cell culture. The total phenolic, flavonoid, and anthocyanin concentrations of 
the grape extract were determined using the Folin assay, and according to the methods of 
Kim, Lee and colleagues [181, 182] as described earlier.  
 
Cell Treatment 
 RAW264.7 cells were plated on a 96-well plate at a seeding density of 2 X 105 
cells/well. The cells were incubated for 24 hours at 37ºC with 5% CO2, then the media 
was removed and the cells were washed with PBS. The cells were then treated with grape 
extract (0, 0.01, 0.1, and 1%) in complete media and incubated for 24 hours.  The media 
was removed and the cells were washed with PBS. Finally, the cells were stimulated with 
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500 ng/ml LPS and incubated for another 24 hours.  After LPS treatment, media was 
collected for nitric oxide analysis and the remaining cells were used to assess cell 
viability. All experiments were repeated at least three times. These methods were 
described earlier. 
 
Table 4:  Ten Grapes Varieties Chosen for in vitro Investigation of Anti-Inflammatory 
Properties of Grape Extract1 
Varieties Total Phenolic (mg/L) NO Production (µM) 
Cabernet Sauvignon 312.9 ± 30.9 40.7 
Chardonney 294.6 ± 12.2 58.3 
Cynthiana 524.6 ± 129.1 54.2 
Pinot Gris 264.1 ± 29.4 29.4 
Rubaiyat 689.1 ± 30.8 57.3 
Ruby Cabernet 247.2 ± 29.1 39.9 
Sauvignon Blanc 186 ± 42.3 34.5 
Sunbelt 281.7 ± 86.7 64.4 
Viognier 408.± 75.5 36.6 
Zinfandel 1660 ±93.4 57.0 
 
1Grape varieties were chosen based on total phenolic content (five varieties with 
relatively high total phenolic content and five varieties with relatively low total phenolic 








Specific Aim 3:  To compare the effect of Rubaiyat grape extract, a native Oklahoma 
grape variety, to that of resveratrol on expression of inflammatory genes in LPS-
stimulated RAW264.7 macrophages. 
 
Cell Treatment 
 RAW 264.7 macrophages were plated into a six-well plate at a seeding density of 
2 X 106  cells/well. After 24 hours, cells were induced with 500 ng/ml LPS and treated 
with 30 µM resveratrol (Sigma Aldrich, St. Louis, MO) , 0.1%  Rubaiyat grape extract,  
or 1% Rubaiyat grape extract and a control of media only. The following day the 
supernatant was removed and analyzed for nitric oxide production (Greiss reagent, 
Promega) and the remainder stored at -80°C for cytokine analyses.  The RNA was 
extracted from the cells for the assessment of expression of inflammatory genes. 
 
RNA Extraction  
 RNA STAT-60TM (Iso-tex Diagnostics Inc, Friendswood, TX) was added to each 
well (1 ml/ 5 X 106 cells) to isolate the cellular RNA. The lysate was transferred to an 
RNase free centrifuge tube and stored for 5 minutes at room temperature to permit the 
complete dissociation of nucleoprotein complexes. Chloroform was then added (0.2 
ml/ml of the RNA STAT-60TM ) to the homogenate, mixed, allowed to  stand at room 
temperature for 2-3 minutes, and centrifuged at 12,000 g for 15 minutes at 4oC. The clear 
aqueous phase was carefully transferred to a new tube. Isopropanol (0.5 ml/ml STAT-
60TM) was added to precipitate the RNA, placed at -80°C for 1 hour, and centrifuged at 
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12,000 g for 10 minutes at 4°C.  The supernatant was removed and the RNA pellet was 
washed once with 75% ethanol, vortexed and centrifuged at 7,500 g for 5 minutes at 4oC. 
After centrifugation, the supernatant was poured off and the RNA pellet was air-dried. 
The pellet was dissolved in DEPC water and vortexed. The yield and quality of RNA was 
assessed with the nanodrop spectrophotometer (Nanodrop, Wilmington, DE).  
 
Assessment of Inflammatory Gene Expression by Real Time-PCR 
A working stock of reverse and forward primers for COX-2, IL-6, iNOS, TNF-α, 
and cyclophilin were prepared in DEPC water at a final concentration of 2.5 µM for each 
primer.  The primer working stock, SYBR green, and DEPC-water were mixed to create 
the PCR Mastermix. DNA sample was pipetted into its respective well according to the 
prepared template and the PCR Mastermix was then added to each well. The plate was 
sealed well and spun at 3000 rpm for 5 minutes.  
 Detection of the reaction was performed on a 384-well plate in a 10 μL reaction 
mix containing unkown cDNA samples, forward and reverse primers, and SYBR Green I 
PCR reagents (Applied Biosystems, Foster City, CA, USA). The primers used for PCR 
are shown in Table 5. Amplifications of RNA were detected constantly by realtime 
quantitative PCR on 7900 HT Fast Real-time PCR system (Applied Biosystems, Foster 
City, CA). The  PCR amplification protocol is as follows: (i) initial attenuation at 95°C 
for 10 minutes; and (ii) three-segment amplification and quantification involving 40 
cycles of 50°C for 120 s, 95°C for 10 min, 95°C for 9 s,  60°C for 60 s, 95°C for 9 s, and  




Table 5:  Primer Sequences used for Real-time PCR. 
 
Symbol Name Sequence 
COX-2 Cyclooxygenase-2 QF 5'tgaagacgtcctccactcatg3’ 
  QR 5'cctgggatggcatcagttt3’ 
IL-6 Interleukin-6 QF 5'gaggataccactcccaacagacc3’ 
  QR 5'aagtgcatcatcgttgttcataca3’ 
iNOS Inducible Nitric Oxide Synthase QF 5'caggaggagagagatccgattta3’ 
  QR 5'gcattagcatggaagcaaaga3’ 
TNF-α Tumor Necrosis Factor Alpha QF 5`ctgaggtcaatctgcccaagtac3` 
  QR 5`cttcacagagcaatgactccaaag3` 
CYCLO Cyclophilin QF 5`tggagagcaccaagacagaca3` 
 




ELISA Assays for TNF-α and IL-6  
  Enzyme linked immunosorbent assay (ELISA) kits from BD Biosciences (San 
Diego, CA) were used to determine concentrations of TNF-α and IL-6 in the media. The 
wells of microtiter plate were coated with anti-mouse TNF-α and IL-6 monoclonal 
antibodies before use. The plate was then coated with second biotinylated anti-mouse 
polyclonal antibody to capture the analytes in the samples. Unbound materials from 
samples were then washed off and horseradish peroxidase was applied to the immobilized 
biotinylated antibodies. The activity of horseradish peroxidase was monitored using 3, 3’, 
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5, 5’-tetramethylbenzidine as a substrate and absorbance at 450 nm was measured using a 
microplate reader (Biotek Synergy, Winooski, VT). The captured mouse TNF-α and IL-6 




Statistical analyses involved computation of least square means and standard error 
(SE) for each of the treatment groups using SAS version 9.1 (SAS Institute, Cary, NC). 
Analysis of variance and least square means were calculated using the general linear 
model procedure and the means were compared using Fisher’s least significant difference 






Specific Aim 1: To determine the phenolic content, anti-oxidant capacity, and anti-
inflammatory properties of juice from different varieties of grapes grown in Oklahoma 
 
Total Phenolic, Flavonoid, Anthocyanin, and Anti-Oxidant Capacity of Grape Juice 
  Two methods of preparation of grape juice were used in the first part of the study 
– smashed and pureed. Total phenolic, flavonoid, anthocyanin, and anti-oxidant capacity 
(FRA) were all significantly less in the juice obtained by smashing the grapes compared 
to the pureed grapes (Figure 1). The total phenolic and flavonoid concentration of the 
pureed grapes was more than double the concentration from the smashed grapes (Figures 
1A and 1B).  A greater difference was noted in the anthocyanin and FRA concentrations 
of the juice from smashed grapes which was approximately only one-third the 
concentration of juice from pureed grapes (Figures 1C and 1D).  
 For most of the grape varieties except for Cynthiana, H2 #211, H5 #125, Shiraz, 
and Viognier, the total phenolic concentration of the juice obtained by pureeing was 
significantly higher than those obtained from smashing (Table 6 and 7). This trend was 
also reflected in the flavonoid concentration where nearly 80% of the grape varieties had 
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Figure 1:  Effect of Grape Juice Preparation on (A) Total Phenolic, (B) Flavonoid, (C) 
Anthocyanin, (D) Anti-Oxidant Capacity (FRA) from Combined Data of Thirty-three 
































































      




















































Bars are mean ± SD. Bars that do not share the same letters are significantly (P < 0.05) 
different.
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significantly higher flavonoid concentration in pureed grapes in comparison to smashed 
grapes except for Chardonel, Frontenac, H5 #125, Pinot Gris, Vignoles, and Villard 
Blanc which displayed no significant difference in between juice preparations (Table 6 
and 7).  Only about half of the varieties showed a significant difference between 
preparations for anthocyanin and FRA concentration (Table 6 and 7). As expected, the 
white grapes (Chardonel, Chardonney, Sauvignon Blanc, Traminette, Vignoles, Villard 
Blanc, and Viognier) except for the White Riesling all had low to zero anthocyanin 
concentration and FRA values (Table 6 and 7).  Grape varieties with high anthocyanin 
concentration (Rubaiyat, Sunbelt, and Frontenac except for Zinfandel) also had high FRA 
concentrations (Table 6 and 7).  
  When comparing smashed grape juice only, total phenolic concentration was 
significantly higher in Petit Verdot (794.8±91.5 mg/L) and Rubaiyat (689.1±30.8 mg/L), 
which are purple grapes, and H1 #249 (752.3±189.3 mg/L), a pink grape (Table 7).  The 
grape variety with the lowest total phenolic concentration was Chardonel (162.4±72.5 
mg/L) which is statistically similar to Pinot Gris (264.1±29.4 mg/L), Traminette 
(203.3±31.8 mg/L), White Riesling (202.4±6.4 mg/L), Villard Blanc (193.0±64.6 mg/L), 
and Sauvignon Blanc (186.0±42.3 mg/L), all white grapes and Cabernet Franc 
(250.8±33.1 mg/L), GG 9336 (225.2±6.4 mg/L) which are red grapes (Table 7). The 
grape varies with the highest flavonoid concentrations of the smashed preparation were 
Frontenac (30.1±4.7 mg/L) and Rubaiyat (30.1±6.4 mg/L) while the lowest flavonoid 
concentration was found in the Pinot Gris (0.5±0.9 mg/L) (Table 7). Rubaiyat had the 
highest anthocyanin concentration (143.9±1.3 mg/L) while Sauvignon Blanc and Villard 
Blanc, both white grapes, had very little or no anthocyanin content (Table 7).  
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Table 6: Total Phenolic, Flavonoid, Anthocyanin, and Anti-Oxidant Capacity (FRA) of 











FRA Valuef (µM) 
      
Cabernet Franc *805.6 ± 18.3 *51.6 ± 3.5 12.3 ± 6.0 *628.9 ± 291.1 
Cabernet Sauvignon *586.0 ± 24.0 *24.5 ± 3.7 9.1 ± 2.2 *217.8 ± 35.9 
Chambourcin *825.8 ± 162.9 *13.5 ± 2.9 53.9 ± 25.1 775.4 ± 451.7 
Chardonel *585.7 ± 16.5 14.3 ± 2.2 0.4 ± 0.3 5.7 ± 5.4 
Chardonnay *361.6 ± 2.8 *14.2 ± 1.4 0.4 ± 0.5 6.0 ± 7.2 
Cimmaron *952.4 ± 125.7 *57.1 ± 3.8 5.1 ± 4.9 277.0 ± 258.7 
Corot Noir *1500.9 ± 17.1 *109.0 ± 9.6 *81.8 ± 23.3 *8865.8 ± 2519.2 
Cynthiana 744.7 ± 125.4 *22.2 ± 1.2 38.6 ± 15.8 846.5 ± 325.5 
Frontenac *1072.1 ± 51.5 34.0 ± 1.6 *149.0 ± 16.2 *5059.0 ± 573.4 
Gamay *681.5 ± 179.5 *24.6 ± 1.1 *10.7 ± 0.6 *264.0 ± 5.3 
GG 9318 *643.4 ± 44.6 *77.7 ± 7.3 *70.0 ± 8.8 *5469.3 ± 1072.0 
GG 9330 *689.2 ± 15.1 *43.2 ± 1.4 *66.2 ± 15.5 *2856.4 ± 677.4 
GG 9336 *732.4 ± 35.0 *24.5 ± 1.5 *9.2 ± 2.2 *223.5 ± 44.0 
GG 9356 *829.0 ± 96.5 *30.4 ± 1.1 *25.0 ± 1.4 *759.8 ± 50.9 
H1 #249 *1843.8 ± 240.3 *38.8 ± 4.0 9.4 ± 9.3 384.1 ± 398.8 
H2 #211 1172.0 ± 349.2 *20.7 ± 7.0 38.5 ± 18.8 *726.2 ± 301.5 
H5 #125 1035.4 ± 286.6 18.2 ± 2.6 *16.7 ± 3.6 *309.6 ± 103.7 
Merlot *1025.9 ± 251.8 *37.1 ± 2.4 *18.3 ± 7.1 *685.7 ± 298.4 
Montepulciano *1086.7 ± 307.8 *35.0 ± 1.6 *29.8 ± 9.3 *1032.7 ± 281.5 
Petit Verdot *1817.7 ± 289.9 *63.3 ± 1.2 40.8 ± 24.8 *2571.8 ± 1549.7 
Pinot Gris *607.1 ± 97.3 17.5 ± 15.6 1.1 ± 1.0 22.9 ± 37.5 
Rubaiyat *1154.1 ± 37.0 *45.3 ± 4.6 *266.1 ± 42.1 *11939.2 ± 1208.6 
Ruby Cabernet *427.1 ± 96.8 20.5 ± 3.7 36.2 ± 13.4 *713.6 ± 210.9 
Sangiovese *433.3 ± 17.0 *29.9 ± 3.0 *24.7 ± 7.4 *726 ± 160.4 
Sauvignon Blanc *299.6 ± 47.5 *17.1 ± 0.4 *1.0 ± 1.0 17.8 ± 16.4 
Shiraz 236.5 ± 17.9 *15.8 ± 1.4 *9.5 ± 2.9 *150.8 ± 49.5 
Sunbelt *1512.9 ± 128.7 *37.4 ± 2.8 *149.6 ± 12.8 *5571.7 ± 353.0 
Traminette *529.1 ± 105.8 *3.1 ± 0.3 0.4 ± 0.7 1.4 ± 2.4 
Vignoles *840.0 ± 223.8 23.9 ± 0.5 *0.0 ± 0.0 0.0 ± 0.0 
Villard Blanc *443.6 ± 16.0 13.6 ± 1.2 *0.0 ± 0.0 0.0 ± 0.0 
Viognier 630.6 ± 129.9 *52.8 ± 0.1 *0.0 ± 0.0 0.0 ± 0.0 
White Riesling *1275.5 ± 170.2 *41.0 ± 1.9 *0.5 ± 3.8 106.9 ± 149.8 
Zinfandel *1660.6 ± 557.4 *77.3 ± 2.1 *2.1 ± 8.1 1810.2 ± 641.0 
 
aValues or mean ± SD. Superscript letters are comparison of varieties. Values that do not share the same letter are significantly 
different (P < 0.05) from each other. Asterisk represent significant difference (P < 0.05) between  the methods of preparation (smashed 
vs. pureed) for a particular grape variety. 
bObtained from Cimarron Valley Research Station (Perkins, OK) in 2007.   
cDetermined by the Folin-Ciocalteau assay 
dDetermined by the aluminum chloride assay    
eDetermined by the pH differential assay 
fDetermined by the FRAP assay 
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Table 7: Total Phenolic, Flavonoid, Anthocyanin, and Anti-Oxidant Capacity of 
Oklahoma Grapes by Smashed Preparationa 
 
 






FRAP Valuef (µM) 
Cabernet Franc 250.8 ± 33.1lmno 9.2 ± 2.4ghi 3.3 ± 0.7fgh 30.7 ± 13.7c 
Cabernet Sauvignon 312.9 ± 30.9hijkl 1.1 ± 1.9mn 0.6 ± 0.6gh 0.1 ± 0.1c 
Chambourcin 375.5 ± 47.0ghijk 6.0 ± 2.7ijkl 41.6 ± 5.6c 254.0 ± 119.7c 
Chardonel 162.4 ± 72.5o 14.9 ± 1.0cdef 0.4 ± 0.3gh 6.3 ± 5.3c 
Chardonnay 294.6 ± 12.2ijklmn 7.7 ± 2.1hijk 0.8 ± 0.5gh 5.1 ± 3.0c 
Cimmaron 634.4 ± 15.7bcd 13.5 ± 1.4ef 0.4 ± 0.6gh 4.7 ± 7.1c 
Corot Noir 439.1 ± 119.3efg 4.7 ± 2.5jklm 10.1 ± 3.2e 42.2 ± 8.4c 
Cynthiana 524.6 ± 129.1def 18.0 ± 1.1cd 29.8 ± 6.4d 538.2 ± 139.3c 
Frontenac 233.4 ± 23.3lmno 30.1 ± 4.7a 116.7 ± 11.7b 3481.1 ± 237.4b 
Gamay 375.7 ± 41.2ghijk 7.0 ± 2.2ijkl 2.0 ± 0.8fgh 15.2 ± 11.2c 
GG 9318 307.4 ± 40.1hijklm 7.5 ± 1.1hijk 5.6 ± 2.4efg 40.1 ± 13.4c 
GG 9330 292.4 ± 35.0ijklmn 6.1 ± 1.2ijkl 1.6 ± 0.9fgh 10.0 ± 6.9c 
GG 9336 225.2 ± 6.4lmno 7.0 ± 1.5ijkl 1.6 ± 0.5fgh 11.0 ± 3.4c 
GG 9356 529.8 ± 50.3de 22.6 ± 3.7b 6.7 ± 3.6ef 144.6 ± 65.2c 
H1 #249 752.3 ± 189.3ab 11.9 ± 1.3fg 2.5 ± 1.6fgh 28.6 ± 15.4c 
H2 #211 628.6 ± 42.9cd 7.6 ± 1.3hijk 24.5 ± 3.7d 186.7 ± 39.3c 
H5 #125 532.2 ± 177.3de 18.5 ± 0.9c 3.2 ± 2.5fgh 58.6 ± 46.9c 
Merlot 567.4 ± 126.0d 4.7 ± 1.2jklm 1.2 ± 2.0gh 4.3 ± 7.4c 
Montepulciano 385.6 ± 15.2ghij 6.9 ± 1.4ijkl 1.4 ± 0.9fgh 9.4 ± 6.3c 
Petit Verdot 794.8 ± 91.5a 11.4 ± 1.9fgh 5.5 ± 5.0efgh 60.3 ± 59.3c 
Pinot Gris 264.1 ± 29.4klmno 0.5 ± 0.9n 0.4 ± 0.3gh 0.2 ± 0.3c 
Rubaiyat 689.1 ± 30.8abc 30.1 ± 6.4a 143.9 ± 1.3a 4331.1 ± 874.8a 
Ruby Cabernet 247.2 ± 29.1lmno 3.8 ± 3.3klmn 3.8 ± 2.5fgh 9.6 ± 11.0c 
Sangiovese 208.8 ± 43.1lmno 8.0 ± 0.9ghij 1.9 ± 2.0fgh 13.7 ± 14.5c 
Sauvignon Blanc 186.0 ± 42.3no 7.6 ± 0.3hijk 0.1 ± 0.2h 0.9 ± 1.5c 
Shiraz 269.7 ± 35.9jklmno 11.4 ± 2.0fgh 2.1 ± 0.6fgh 23.6 ± 2.6c 
Sunbelt 281.7 ± 86.7jklmno 14.4 ± 1.1def 38.0 ± 7.3c 543.9 ± 66.0c 
Traminette 203.3 ± 31.8lmno 1.4 ± 0.1mn 0.3 ± 0.5gh 0.4 ± 0.6c 
Vignoles 408.4 ± 75.7fghi 22.8 ± 3.8b 0.2 ± 0.3gh 4.1 ± 4.9c 
Villard Blanc 193.0 ± 64.6mno 5.7 ± 5.1ijkl 0.2 ± 0.2h 0.5 ± 0.9c 
Viognier 424.7 ± 35.7efgh 3.4 ± 1.7lmn 0.7 ± 0.8gh 2.9 ± 4.5c 
White Riesling 202.4 ± 6.4lmno 3.2 ± 0.8lmn 0.5 ± 0.2gh 1.7 ± 0.4c 
Zinfandel 273.9 ± 93.4jklmno 16.8 ± 1.9cde 2.1 ± 0.8fgh 2826.1 ± 2844.6b 
 
aValues or mean ± SD. Superscript letters are comparison of varieties. Values that do not share the same letter are significantly 
different (P ≤ 0.05) from each other. 
bObtained from Cimarron Valley Research Station (Perkins, OK) in 2007.   
cDetermined by the Folin-Ciocalteau assay 
dDetermined by the aluminum chloride assay    
eDetermined by the pH differential assay 
fDetermined by the FRAP assay 
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 The highest FRA value was produced by Rubaiyat which was significantly higher 
than all the other varieties, especially the white grapes which displayed very little to zero 
anti-oxidant capacity (Table 6). There was a significant correlation between anthocyanin 
(R2 = 0.7870, P < 0.001) and flavonoid (R2= 0.6210, P < 0.001) concentration with 
antioxidant capacity (Figures 2B and 2C). However, no correlation between total 


















Figure 2:  Correlation of (A) Total Phenolic, (B) Flavonoid, and (C) Anthocyanin 
Concentrations with Anti-oxidant Capacity (FRA) of all Grape Juices 





























































Effect of Grape Juice on Nitric Oxide Production and Cell Viability of LPS-stimulated 
RAW264.7 Macrophages 
The grape juice prepared by smashing was used to determine its effect on NO 
production and cell viability of LPS-stimulated macrophages. The effect of each variety 
of juice on NO production was compared to those macrophages that were not treated with 
grape juice. All grape varieties significantly reduced NO production in LPS-stimulated 
macrophages compared to those not treated with grape juice (Figure 3). Over half of the 
varieties were statistically similar to Sauvignon Blanc, the grape variety with the greatest 
inhibition of NO production (Figure 3). H2 #211 is the grape variety that exhibited the 
least inhibition of NO production, yet, it was still significantly less than the NO produced 
by the untreated cells (Figure 3). The other half of the varieties were statistically similar 
to H1 #211 in inhibiting NO production (Figure 3).  
There was a significant correlation (R2 = 0.113, P = 0.026) with NO production 
and total phenolic content of all varieties of grape juice used for the treatment of LPS-
stimulated macrophages (Table 8). However, there was no correlation between NO 
production and flavonoid and anthocyanin content of the grape juice (Table 8). 
Treatment with LPS and grape juice did not cause cytotoxic effects in RAW264.7 
macrophage (Figure 4). Pinot Gris had more than 100% viable cells (128.4% compared 
to the cells not treated with juice) and twenty-five percent of the varieties have similar 
effects with Pinot Gris (Figure 4) suggesting that the cells may have been stimulated to 
proliferation. Cimarron had the lowest viability (92.7% compared to cells not treated with 
juice) which was statistically similar to the remaining twenty-four varieties (Figure 4). 
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Figure 3:  Effect of Juice from Thirty-three Oklahoma Grape Varieties on Nitric Oxide 

















































































































































































































++ +++ + + ♦ + ♦ + +♦ + ♦ ♦ ♦ ++ + ♦ + + ♦ ♦♦ ♦♦ ♦♦ ♦♦♦
 
1Bars are mean ± SD; experiment was repeated at least three times. 
*LPS-stimulated macrophage not receiving juice has significantly (P < 0.05) higher nitric 
oxide production compared to those receiving grape juice. 
+ H2 #211 is the grape variety with the least inhibition of NO production.  Other varieties 
sharing the symbol ‘+’ are statistically similar to H2 #211 in inhibiting NO production. 
♦ Sauvignon Blanc is the grape variety with the highest inhibition of NO production. 
Other varieties sharing the symbol ‘♦’ are statistically similar to Sauvignon Blanc in 








Table 8:  Correlation of Nitric Oxide (NO) Production from LPS-stimulated Macrophage 




  Total Phenolic Flavonoid Anthocyanin 
NO Pearson Correlation 0.113 0.006 0.063 
 P value 0.026* 0.457 0.139 
*P < 0.05 is considered significant 
 
 
Figure 4:  Effects of Juice from Different Oklahoma Grape Varieties on Cell Viability of 






































































































































































































+ + ++ +
♦+ ♦ + 
♦ ♦ ♦ ♦ +♦ ♦ ♦ ♦ ♦ ♦ ♦
♦ ♦ ♦ ♦ ♦ ♦ ♦ ♦ ♦♦
♦ 
 
1Bars are mean ± SD; experiment was repeated at least three times. 
+  Pinot Gris is the variety with highest cell viability (P<0.05).  Bars that share the 
symbol ‘+’ have statistically similar cell viability to Pinot Gris. 
♦  Cimarron is the variety with the lowest cell viability (P<0.05).  Bars that share the 
symbol ‘♦’ have statistically similar cell viability to Cimarron. 
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In addition to comparing different varieties, the effect of different concentrations 
(0, 1, 5 and 10%) of grape juice on NO production and cell viability were also assessed. 
Treatment with grape juice dose-dependently inhibited NO production (Figure 5A).  
Grape juice concentration starting at 1% significantly decreased the amount of NO 
produced in comparison to those not treated with grape juice.  Meanwhile, the 5% and 
10% juice were significantly more effective inhibitors of NO production with no 
difference in the inhibition of NO production between 5 and 10% juice (Figure 5A). The 
cell viability assay shows that there was no cytotoxic effects in any of the concentrations 
of juice used (Figure 5B). However, cells treated with 1% grape juice have significantly 














Figure 5:  Effect of Different Concentration of Grape Juice from Thirty-three Oklahoma 






















1Bars are mean ± SD. Experiment was repeated at least three times. Bars that do not share 




Specific Aim 2:  To assess the in vitro anti-inflammatory properties of extract from 
Oklahoma grape varieties with high and low total phenolic content using LPS-stimulated 
RAW264.7 macrophage. 
 
Total Phenolic, Flavonoid, and Anthocyanin Concentration of Grape Extract 
 From the findings of specific aim 1, ten grape varieties were chosen to extract the 
polyphenols. The choice of these ten grape varieties was based on the inhibition of NO 
production and total phenolic concentration of the juice from the smashed grapes (results 
of specific aim 1). The ten grape varieties chosen were Sauvignon Blanc, Chardonnay, 
Voignier, Pinot Gris, and Cabernet Sauvignon (relatively low total phenolic content) and 
Cynthiana, Rubaiyat, Ruby Cabernet, Sunbelt, and Zinfandel relatively (relatively high 
total phenolic content).  
Zinfandel extract had the highest concentration of total phenolic (280.9±2.7 
mg/100g), anthocyanin (34.5±3.8 mg/100g), and flavonoid (106.4±7.2 mg/100g) (Table 
9).  Sauvignon Blanc extract had the lowest concentration of total phenolic (63.7± 1.1 










Table 9:  Total Phenolic, Flavonoid, and Anthocyanin Concentration of Extract from Ten 
Oklahoma Grape Varieties1 
 
 






Cabernet Sauvignon 141.5 ± 3.4d 52.8 ± 2.5d 4.5 ± 0.2d
Chardonney 93.3 ± 1.9g 40.6 ± 1.3e 0.0 ± 0.0e
Cynthiana 86.2 ± 0.1h 32.9 ± 0.5fg 30.7 ± 1.8b
Pinot Gris 147.0 ± 2.1c 64.0 ± 1.3c 0.4 ± 0.1e
Rubaiyat 104.8 ± 0.4f 31.0 ± 0.5g 24.0 ± 1.6c
Ruby Cabernet 197.9 ± 2.0b 77.8 ± 1.0b 22.4 ± 0.5c
Sauvignon Blanc 63.7 ± 1.1i 25.6 ± 0.2h 0.1 ± 0.1e
Sunbelt 101.8 ± 1.1f 35.6 ± 1.0f 4.0 ± 0.1d
Viognier 116.7 ± 0.9e 49.2 ± 2.0d 0.0 ± 0.0e
Zinfandel 280.9 ± 2.7a 106.4 ± 7.2a 34.5 ± 3.8a
 
1Values are mean ± SD; experiment was repeated at least three times. For each column, 











Effect of Grape Extract on Nitric Oxide Production and Cell Viability of LPS-
stimulated RAW264.7 Macrophages 
 Grape extract from the ten different varieties did not significantly reduced NO 
production in LPS-stimulated macrophages (Figure 6A).  Macrophage treated with 
Zinfandel extract produced significantly more NO than Cabernet Sauvignon, 
Chardonnay, Rubaiyat, and Sauvignon Blanc extract (Figure 6A).  There were no 
statistical differences in the cell viability of the macrophages (Figure 6B). 
The LPS-stimulated RAW264.7 macrophages were also treated with different 
concentrations (0, 0.01, 0.1, and 1%) of grape extract.  The 0.01% grape extract showed a 
significant increase of NO production while the 1% showed a significant decrease in NO 
production in comparison to those not given grape extract (Figure 7A).  There was no 
difference in NO production between the 0 and the 0.1% grape extract (Figure 7A). The 
cell viability of the 0.01% and 0.1% concentrations were statistically greater than the 0 
and the 1% extract (Figure 7B).  NO production was significantly reduced from 0.01% to 









Figure 6:  Effects of Extract from Ten Oklahoma Grape Varieties on (A) Nitric Oxide 
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1Bars are mean ± SD; experiment was repeated at least three times. Bars that do not share 
the same letters are significantly different (P < 0.05) from each other. 
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Figure 7:  Effect of Different Concentration of Grape Extract from Ten Oklahoma Grape 












1Bars are mean ± SD; experiment was repeated at least three times. Bars that do not share 
the same letters are significantly different (P < 0.05) from each other. 
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Figure 8:  Effect of Different Concentration of Grape Extract from Ten Oklahoma Grape 



















































1Bars are mean ± SD; experiment was repeated at least three times. For each variety, 










Specific Aim 3:  To compare the effect of Rubaiyat grape extract, a native Oklahoma 
grape variety, to that of resveratrol on expression of inflammatory genes in LPS-
stimulated RAW264.7 macrophages. 
 
Nitric Oxide, TNF-α, and IL-6 
 Treatment with LPS increased NO production in macrophages and resveratrol 
reduced NO production in these cells (Figure 9A).  The two doses of Rubaiyat grape 
extract 0.1% and 1% did not reduce LPS-induced production of NO (Figure 9A).  
LPS-stimulated macrophages had increased production of TNF-α and neither 
Rubaiyat grape extract nor resveratrol reduced TNF-α production (Figure 9B). LPS-
stimulated macrophages treated with Rubaiyat grape extract, particularly 0.1% dose, had 
the highest IL-6 concentration (Figure 9C).  LPS-stimulated macrophages treated with 












Figure 9:  Effect of Resveratrol and Rubaiyat Grape Extract on (A) Nitric Oxide, (B) 
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1Bars are mean ± SD; experiment was repeated at least three times. Bars that do not share 






Real Time PCR 
 The expression of four pro-inflammatory genes, COX-2, IL-6, iNOS, and TNF-α 
were examined with real-time RT-PCR.  LPS significantly increased gene expression of 
IL-6 and iNOS (Figures 10A and 10B). Resveratrol and the higher dose of Rubaiyat 
grape extract reduced the gene expression of IL-6 and iNOS to the level of the 
unstimulated macrophages (Figures 10A and 10B).  The lower dose of Rubaiyat grape 
extract (0.1%) did not reduce IL-6 or iNOS expression (Figures 10A and 10B).  There 
were no significant differences in the relative mRNA of COX-2 and TNF-α (Figures 10C 















Figure 10:  Effect of Resveratrol and Rubaiyat Grape Extract on Relative Abundance of  
mRNA for (A) IL-6, (B) iNOS, (C) COX-2, (D) TNF-α in RAW264.7 Macrophage1  
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1Bars are mean ± SD; experiment was repeated at least three times. Bars that do not share 







The primary objective of this study is to compare the phenolic content of 
Oklahoma grapes and determine anti-oxidant and anti- inflammatory properties.  The 
hypothesis of the study is that the variety of Oklahoma grapes with high concentration of 
polyphenols will decrease markers of inflammation using murine macrophages.   
Our findings show that the method of juice preparation has a significant effect on 
phenolic content. Over eighty percent of the varieties had significantly more total 
phenolic content by using the entire berry compared to just using the pulp.  This indicates 
that the greater portions of phenolics are in the skin and seeds.  Anthocyanin 
concentration was found to be highest in Rubaiyat grapes but reduced dramatically when 
only the juice of the pulp was assessed indicating that anthocyanin is present primarily in 
the skins of purple/red grapes.  Anthocyanin concentrations ranged from as high as 266 
mg/L to as low as 5 mg/L among varieties of purple grapes.  The total phenolics of our 
purple grape juices tended to be comparable to Concord grape juice which has been 
reported around 1800 mg/L [144, 184, 185]. 
The antioxidant activity of the juice was found to have a strong correlation with 
anthocyanin but not with total phenolic. Orak and colleagues [125] found different results 
reporting the correlation between antioxidant activity and total phenolic stronger than 
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anthocyanin concentration. Kalt and colleagues [186], on the other hand, found a strong 
correlation between both total phenolic and anthocyanins with antioxidant activity [186].  
This indicates that the antioxidant activity of grape cultivars is not directly associated 
with the presence of anthocyanin. Anthocyanin alone has been well documented as 
having antioxidant properties but a synergistic effect with anthocyanin and other phenolic 
compounds found in grapes may enhance the antioxidant activity in grape cultivars that 
do not have high concentrations of anthocyanins. 
Grape juice made from pulp only was used to assess NO production in LPS-
stimulated RAW264.7 murine macrophages. Sauvignon Blanc, a white grape, inhibited 
NO production the greatest accompanied by other white grapes Traminette, Viognier, and 
Vignoles. This indicates that there are phenolic compounds present in the pulp of 
different varieties of grapes capable of inhibiting NO production and it is not dependent 
on the amount of phenolic compounds. This agrees with the findings of Shanmugam et al 
[130] demonstrating that other plants with high polyphenolic content were unable to 
inhibit NO production indicating that only certain polyphenols or combination of 
polyphenols are responsible. 
The total phenolics and anthocyanin content of purple grape extract  have been 
reported to be between 817 and 3062 mg/L [125] and 40.3 to 990.8 mg/L [125], 
respectively. White grapes tend to have a much lower total phenolic concentration [126] 
and extremely low to no anthocyanin content.  Ten grape varieties were chosen to further 
investigate the anti-inflammatory properties of grape extract. Our purple grape extracts 
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fell into the range of published data but the white grape extract of some varieties 
produced a much higher total phenolic than what was reported [126].  Only four of the 
extracts significantly inhibited NO production in LPS-stimulated RAW264.7 
macrophages:  two purple/red varieties (Cabernet Sauvignon and Rubaiyat) and two 
white varieties (Chardonnay and Sauvignon Blanc). When comparing the dose-dependent 
effect, we found that one percent extract was approximately 50% more effective than the 
control in reducing NO production. Our findings do not agree with our hypothesis that 
the higher total phenolic concentration will decrease NO production. 
For the third aim of our study, we compared the effect of the Rubaiyat grape 
extract to that of resveratrol. Resveratrol has been shown to be a powerful antioxidant 
and exhibits many cardioprotective effects [129, 140, 162, 187-195]. Resveratrol has 
been documented to significantly inhibit NO production at a wide range of concentrations 
(3 – 30 µM)  and also reported to be cytotoxic at 50 µM [196].  The effect of Rubaiyat 
grape extract was compared to resveratrol (30µM) on NO production and mRNA 
expression of TNF-α, IL-6, iNOS and COX-2. Rubaiyat grape extract was found to be 
most effective in inhibiting NO production starting at a concentration of 1% (30 µg/ml) 
or higher but cytotoxic at 10%. At this time, it cannot be determined if resveratrol present 
in Rubaiyat grapes is responsible for its effect on NO or other phenolic substances found 
in grapes such as procyanidin [156], proanthocyanidin [197-199] and anthocyanin [125, 
200].  An analysis of all the phenolic substances present in Rubaiyat grapes would need 
to be done to determine which would be most effective. 
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Markers of inflammation assessed in this study were TNF-α, IL-6, iNOS, and 
COX-2. A compound that would inhibit the RNA expression of all four markers is 
desirable. Shanmugam and colleagues [131] found grape seed polyphenols to be active in 
inhibiting NO and TNF-α. Sung et al [201] investigated the preventative effect of  a 
resveratrol tetramer against LPS induced inflammation and found that only iNOS 
displayed a dose dependent reduction in expression and no change in the TNF-α and IL-6 
expression.  A similar study conducted by Bi and colleagues [109] showed that besides a 
reduction in iNOS expression, there was also a reduction in TNF-  expression in 
microglia cells treated with resveratrol.  As for COX-2 expression, grape polyphenols 
completely inhibited the increase in rats with inflammation due to ethanol treatment [202] 
and was also decreased by resveratrol [203]. In our study, iNOS  and IL-6 expression 
were significantly decreased when treated with resveratrol and the 1% Rubaiyat extract, 
but TNF-α and COX-2 expression were not significantly different from the control. And 
although there was no reduction in the production of IL-6, there was a significant 
decrease of IL-6 expression. This could be accounted for as an accumulation of IL-6 in 
the media. 
The resveratrol content was not measured in our study but other studies have 
found the concentration in purple grape juice to be as high as 0.5 mg/L [204]. Rubaiyat 
grapes grown in Oklahoma have a high total phenolic concentration with a very high 
anthocyanin concentration.  Rubaiyat extract was compared to resveratrol which is 
known for its cardioprotective abilities.  Upon assessment of the inflammatory gene 
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expression Rubaiyat and resveratrol affected each marker in the same way.  IL-6 and 
iNOS were significantly inhibited while COX-2 and TNF-α were not significantly 
affected. At this point there is no way of knowing which phenolic substance is 
responsible for the cardioprotective properties of Rubaiyat grape extract.  Each phenolic 
compound found in Rubaiyat grape extract would need to be analyzed. These findings 
support previous findings by Orak and colleagues [125] that it is not the concentration of 
polyphenols, but  a specific phenolic or the synergy between phenolic compounds.  
In summary, we found that a majority of phenolic compounds are found in the 
skin and seeds of most varieties of grapes with purple grapes having more total phenolics 
and anthocyanins than the white grapes. Yet a high total phenolic content did not 
necessarily represent a high anti-oxidant capacity. Some white grape varieties with low 
total phenolic content had a strong anti-oxidant capacity indicating that a phenolic 
compound found in some white grapes may also be a strong anti-oxidant. In vitro 
investigation of the grape extracts determined that both high and low total phenolic 
concentrations decreased NO production in RAW264.7 murine macrophage. Again, 
indicating that it is not the concentration of phenolics but the type of phenolic responsible 
for reducing inflammation. 
There are several limitations to this study.  First, this study utilizes grapes grown 
only in Cimarron Valley Research Station which is not entirely representative of the rest 
of the state as far as the condition of the soil, amount of rainfall, other environmental 
conditions or disease.  Second, since this study only tested one year of harvest, the year to 
year variation of growing conditions was not accounted for. Third, the appropriate 
storage conditions of all phenolic compounds found in grapes have not been determined. 
Many of the phenolic compounds may have been lost or altered during processing or 
storage at -20°C for a week to a month before analyses. These conditions can influence 
the polyphenol composition and concentration of the phenolic compounds in grapes. 
Nonetheless, the same procedure was used for all varieties and and should be sufficient 
for comparative purposes.  Lastly, this study is an in vitro study using murine 
macrophages. The results should be interpreted with caution and cannot be related 
directly to humans. Studies with animals and subsequently with humans are necessary to 
confirm the findings of this study.  The effects of digestion and metabolism are not 
accounted for in cell culture. 
Based on the results of this study we reject the hypothesis that the variety of 
Oklahoma grapes with high concentration of polyphenols will decrease markers of 
inflammation using murine macrophages.  We have found that it is the type of phenolic 
compound responsible and much investigation is required to determine which one or 
what group is responsible for the anti-inflammatory properties of grapes. 
Further research on Oklahoma grape varieties would be beneficial since it has 
been shown that many phenolic compounds present in grapes have anti-oxidant 
properties and are capable of inhibiting markers of inflammation.  More examination into 
the types of phenolic compounds present in the different varieties of grapes may aid in 
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Scope and Method of Study:   
 Many debilitating chronic conditions are linked to chronic inflammation. Recent 
studies have indicated that a relationship exists between phenolic compounds found in 
grapes and the reduction of chronic inflammation. The increasing trend in Oklahoma 
towards grape production has sparked the need to understand the health benefits 
associated with grapes grown locally, including their anti-inflammatory properties. 
Increased knowledge of the health benefits of grapes may help grape growers promote 
their products and increase their consumption which will help Oklahoma’s viticulture and 
agritourism business. The hypothesis of the study is that the varieties of Oklahoma grapes 
with high concentrations of total phenolic compounds will have the greatest impact on 
decreasing markers of inflammation in vitro. The specific aims of the study were to: (1) 
determine the phenolic content, anti-oxidant capacity, and anti-inflammatory properties 
of juice from different varieties of grapes grown in Oklahoma; (2) assess the in vitro anti-
inflammatory properties of extract from Oklahoma grape varieties with high and low total 
phenolics content (five varieties each) using lipopolysaccharide (LPS)-stimulated RAW 
264.7 macrophages; and (3) to compare the effect of the grape extract from an Oklahoma 
grape variety to that of resveratrol on the expression of inflammatory genes in LPS-
stimulated macrophages. 
  
  The majority of phenolic compounds are found in the skin and seeds. Generally, 
purple grapes have more total phenolics and anthocyanins than the white grapes. A high 
total phenolic content did not necessarily represent a high anti-oxidant capacity. Some 
white grape varieties with low total phenolic content had a strong anti-oxidant capacity 
indicating that a phenolic compound found in some white grapes may also be a strong 
anti-oxidant. In vitro investigation of the grape extracts determined that both high and 
low total phenolic concentrations decreased NO production in LPS-stimulated 
macrophages, again, indicating that it is not the concentration of phenolics but the type of 
phenolic compound responsible for reducing inflammation. Resveratrol and the 1% dose 
of Rubaiyat grape extract reduced the gene expression of IL-6 and iNOS to the level of 
the unstimulated macrophage. Investigation on the types of phenolic compounds present 
in the different grape varieties may aid in determining the anti-inflammatory properties. 
 
